BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB, Arruda I, Robinson MO. A mammalian telomerase-associated protein. Science. 1997;275:973-977. [PMID: 9020079 DOI: 10.1126/science.275.5302.973] [Cited by in Crossref: 435] [Cited by in F6Publishing: 439] [Article Influence: 17.4] [Reference Citation Analysis]
Number Citing Articles
1 Martı́n-rivera L, Blasco MA. Identification of Functional Domains and Dominant Negative Mutations in Vertebrate Telomerase RNA Using an in VivoReconstitution System. Journal of Biological Chemistry 2001;276:5856-65. [DOI: 10.1074/jbc.m008419200] [Cited by in Crossref: 45] [Cited by in F6Publishing: 28] [Article Influence: 2.1] [Reference Citation Analysis]
2 Sam M, Wurst W, Klüppel M, Jin O, Heng H, Bernstein A. Aquarius, a novel gene isolated by gene trapping with an RNA-dependent RNA polymerase motif. Dev Dyn 1998;212:304-17. [DOI: 10.1002/(sici)1097-0177(199806)212:2<304::aid-aja15>3.0.co;2-3] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ichiyoshi H, Kiyozuka Y, Kishimoto Y, Fukuhara S, Tsubura A. Massive telomere loss and telomerase RNA expression in dexamethasone-induced apoptosis in mouse thymocytes. Exp Mol Pathol 2003;75:178-86. [PMID: 14516782 DOI: 10.1016/s0014-4800(03)00050-9] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
4 Uehara N, Katakura Y, Miura T, Shirahata S. Subtractive screening of genes involved in cellular senescence. Cytotechnology 2001;35:35-42. [PMID: 19003279 DOI: 10.1023/A:1008103230335] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Hosseini-Asl S, Atri M, Modarressi MH, Salhab M, Mokbel K, Mehdipour P. The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters. Int Semin Surg Oncol 2006;3:20. [PMID: 16925810 DOI: 10.1186/1477-7800-3-20] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bachand F, Triki I, Autexier C. Human telomerase RNA-protein interactions. Nucleic Acids Res. 2001;29:3385-3393. [PMID: 11504876 DOI: 10.1093/nar/29.16.3385] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
7 Nozawa K, Maehara K, Isobe K. Mechanism for the reduction of telomerase expression during muscle cell differentiation. J Biol Chem. 2001;276:22016-22023. [PMID: 11279234 DOI: 10.1074/jbc.m011181200] [Cited by in Crossref: 28] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
8 Ding Z, Green AG, Yang X, Chernenko G, Tang S, Pater A. Retinoic Acid Inhibits Telomerase Activity and Downregulates Expression but Does Not Affect Splicing of hTERT: Correlation with Cell Growth Rate Inhibition in an in Vitro Cervical Carcinogenesis/Multidrug-Resistance Model. Experimental Cell Research 2002;272:185-91. [DOI: 10.1006/excr.2001.5412] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
9 Sheng W, Chien Y, Wang TV. The dual role of protein kinase C in the regulation of telomerase activity in human lymphocytes. FEBS Letters 2003;540:91-5. [DOI: 10.1016/s0014-5793(03)00230-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
10 Tesmer VM, Ford LP, Holt SE, Frank BC, Yi X, Aisner DL, Ouellette M, Shay JW, Wright WE. Two inactive fragments of the integral RNA cooperate to assemble active telomerase with the human protein catalytic subunit (hTERT) in vitro. Mol Cell Biol 1999;19:6207-16. [PMID: 10454567 DOI: 10.1128/MCB.19.9.6207] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 3.3] [Reference Citation Analysis]
11 Parsa N. Telomerase: from Aging to Human Cancers. In: Mehdipour P, editor. Telomere Territory and Cancer. Dordrecht: Springer Netherlands; 2013. pp. 1-28. [DOI: 10.1007/978-94-007-4632-9_1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Sýkorová E, Fajkus J. Structure-function relationships in telomerase genes. Biology of the Cell 2009;101:375-406. [DOI: 10.1042/bc20080205] [Cited by in Crossref: 39] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
13 Morii K, Tanaka R, Onda K, Tsumanuma I, Yoshimura J. Expression of Telomerase RNA, Telomerase Activity, and Telomere Length in Human Gliomas. Biochemical and Biophysical Research Communications 1997;239:830-4. [DOI: 10.1006/bbrc.1997.7562] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
14 Sanchini MA, Bravaccini S, Medri L, Gunelli R, Nanni O, Monti F, Baccarani PC, Ravaioli A, Bercovich E, Amadori D, Calistri D. Urine telomerase: an important marker in the diagnosis of bladder cancer. Neoplasia 2004;6:234-9. [PMID: 15153335 DOI: 10.1593/neo.03433] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
15 Dahse R, Mey J. Telomerase in human tumors: molecular diagnosis andclinical significance. Expert Review of Molecular Diagnostics 2014;1:201-10. [DOI: 10.1586/14737159.1.2.201] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
16 Li GZ, Eller MS, Hanna K, Gilchrest BA. Signaling pathway requirements for induction of senescence by telomere homolog oligonucleotides. Exp Cell Res 2004;301:189-200. [PMID: 15530855 DOI: 10.1016/j.yexcr.2004.08.019] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 2.2] [Reference Citation Analysis]
17 Murakami J, Asaumi J, Kawai N, Tsujigiwa H, Yanagi Y, Nagatsuka H, Inoue T, Kokeguchi S, Kawasaki S, Kuroda M, Tanaka N, Matsubara N, Kishi K. Effects of histone deacetylase inhibitor FR901228 on the expression level of telomerase reverse transcriptase in oral cancer. Cancer Chemother Pharmacol 2005;56:22-8. [PMID: 15791453 DOI: 10.1007/s00280-004-0976-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
18 Li Z, Liu YH, Diao HY, Ma J, Yao YL. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem Biophys Res Commun 2015;468:870-6. [PMID: 26585488 DOI: 10.1016/j.bbrc.2015.11.046] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
19 Hahn WC. Role of telomeres and telomerase in the pathogenesis of human cancer. J Clin Oncol 2003;21:2034-43. [PMID: 12743159 DOI: 10.1200/JCO.2003.06.018] [Cited by in Crossref: 100] [Cited by in F6Publishing: 28] [Article Influence: 5.3] [Reference Citation Analysis]
20 Bryan TM, Cech TR. Telomerase and the maintenance of chromosome ends. Current Opinion in Cell Biology 1999;11:318-24. [DOI: 10.1016/s0955-0674(99)80043-x] [Cited by in Crossref: 179] [Cited by in F6Publishing: 64] [Article Influence: 7.8] [Reference Citation Analysis]
21 Crowe DL, Nguyen DC, Tsang KJ, Kyo S. E2F-1 represses transcription of the human telomerase reverse transcriptase gene. Nucleic Acids Res 2001;29:2789-94. [PMID: 11433024 DOI: 10.1093/nar/29.13.2789] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 4.8] [Reference Citation Analysis]
22 Mukhopadhyay NK, Gordon GJ, Maulik G, Doerre G, Liu BC, Bueno R, Sugarbaker DJ, Jaklitsch MT. Histone deacetylation is directly involved in desilencing the expression of the catalytic subunit of telomerase in normal lung fibroblast. J Cell Mol Med 2005;9:662-9. [PMID: 16202213 DOI: 10.1111/j.1582-4934.2005.tb00496.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
23 Salhab M, Jiang WG, Newbold RF, Mokbel K. The expression of gene transcripts of telomere-associated genes in human breast cancer: correlation with clinico-pathological parameters and clinical outcome. Breast Cancer Res Treat 2008;109:35-46. [PMID: 17616810 DOI: 10.1007/s10549-007-9622-8] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
24 Arinaga M, Shimizu S, Gotoh K, Haruki N, Takahashi T, Takahashi T, Mitsudomi T. Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. The Annals of Thoracic Surgery 2000;70:401-5. [DOI: 10.1016/s0003-4975(00)01454-5] [Cited by in Crossref: 31] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
25 Eller MS, Li GZ, Firoozabadi R, Puri N, Gilchrest BA. Induction of a p95/Nbs1-mediated S phase checkpoint by telomere 3' overhang specific DNA. FASEB J 2003;17:152-62. [PMID: 12554694 DOI: 10.1096/fj.02-0197com] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
26 Choi S, Im E, Kang HK, Lee J, Kwak H, Bae Y, Park H, Kim ND. Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells. Cancer Letters 2005;227:153-62. [DOI: 10.1016/j.canlet.2005.01.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 2.4] [Reference Citation Analysis]
27 Ogretmen B, Kraveka JM, Schady D, Usta J, Hannun YA, Obeid LM. Molecular Mechanisms of Ceramide-mediated Telomerase Inhibition in the A549 Human Lung Adenocarcinoma Cell Line. Journal of Biological Chemistry 2001;276:32506-14. [DOI: 10.1074/jbc.m101350200] [Cited by in Crossref: 76] [Cited by in F6Publishing: 28] [Article Influence: 3.6] [Reference Citation Analysis]
28 Yasui W, Tahara H, Tahara E, Fujimoto J, Nakayama J, Ishikawa F, Ide T, Tahara E. Expression of telomerase catalytic component, telomerase reverse transcriptase, in human gastric carcinomas. Jpn J Cancer Res 1998;89:1099-103. [PMID: 9914776 DOI: 10.1111/j.1349-7006.1998.tb00502.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 37] [Article Influence: 1.7] [Reference Citation Analysis]
29 Iwashita K, Ikeda R, Takeda Y, Sumizawa T, Furukawa T, Yamaguchi T, Akiyama S, Yamada K. Major vault protein forms complexes with hypoxia-inducible factor (HIF)-1α and reduces HIF-1α level in ACHN human renal adenocarcinoma cells. Cancer Science 2010;101:920-6. [DOI: 10.1111/j.1349-7006.2009.01481.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
30 Wisman GBA, Knol AJ, Helder MN, Krans M, de Vries EG, Hollema H, de Jong S, van der Zee AG. Telomerase in relation to clinicopathologic prognostic factors and survival in cervical cancer. Int J Cancer 2001;91:658-64. [DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1099>3.0.co;2-7] [Cited by in Crossref: 46] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
31 Eitsuka T, Nakagawa K, Suzuki T, Miyazawa T. Polyunsaturated fatty acids inhibit telomerase activity in DLD-1 human colorectal adenocarcinoma cells: A dual mechanism approach. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2005;1737:1-10. [DOI: 10.1016/j.bbalip.2005.08.017] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
32 Zhang X, Mar V, Zhou W, Harrington L, Robinson MO. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev. 1999;13:2388-2399. [PMID: 10500096 DOI: 10.1101/gad.13.18.2388] [Cited by in Crossref: 442] [Cited by in F6Publishing: 411] [Article Influence: 19.2] [Reference Citation Analysis]
33 Saini N, Srinivasan R, Chawla Y, Sharma S, Chakraborti A, Rajwanshi A. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status. Liver Int. 2009;29:1162-1170. [PMID: 19627485 DOI: 10.1111/j.1478-3231.2009.02082.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
34 Ishikawa F. A tale of mice without ‘tails’. Nat Genet 1997;17:257-8. [DOI: 10.1038/ng1197-257] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
35 Zhu L, Hathcock KS, Hande P, Lansdorp PM, Seldin MF, Hodes RJ. Telomere length regulation in mice is linked to a novel chromosome locus. Proc Natl Acad Sci U S A 1998;95:8648-53. [PMID: 9671732 DOI: 10.1073/pnas.95.15.8648] [Cited by in Crossref: 103] [Cited by in F6Publishing: 99] [Article Influence: 4.3] [Reference Citation Analysis]
36 Vaziri H, Benchimol S. Alternative pathways for the extension of cellular life span: inactivation of p53/pRb and expression of telomerase. Oncogene. 1999;18:7676-7680. [PMID: 10618707 DOI: 10.1038/sj.onc.1203016] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
37 Davis AJ, Siu LL. Telomerase: therapeutic potential in cancer. Cancer Invest 2000;18:269-77. [PMID: 10754994 DOI: 10.3109/07357900009031830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
38 Ohta R, Demachi-Okamura A, Akatsuka Y, Fujiwara H, Kuzushima K. Improving TCR affinity on 293T cells. J Immunol Methods 2019;466:1-8. [PMID: 30468736 DOI: 10.1016/j.jim.2018.11.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
39 Hu BT, Insel RA. Up-regulation of telomerase in human B lymphocytes occurs independently of cellular proliferation and with expression of the telomerase catalytic subunit. Eur J Immunol 1999;29:3745-53. [DOI: 10.1002/(sici)1521-4141(199911)29:11<3745::aid-immu3745>3.0.co;2-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
40 Banerjee PP, Jagadeesh S. Non-radioactive Assay Methods for the Assessment of Telomerase Activity and Telomere Length. In: Chellappan SP, editor. Chromatin Protocols. New York: Springer; 2015. pp. 305-16. [DOI: 10.1007/978-1-4939-2474-5_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
41 Lavelle F, Riou JF, Laoui A, Mailliet P. Telomerase: a therapeutic target for the third millennium? Crit Rev Oncol Hematol 2000;34:111-26. [PMID: 10799836 DOI: 10.1016/s1040-8428(00)00057-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
42 Jagadeesh S, Banerjee PP. Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1. Biochem Biophys Res Commun 2006;347:774-80. [PMID: 16843438 DOI: 10.1016/j.bbrc.2006.06.172] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.9] [Reference Citation Analysis]
43 Bhari VK, Kumar D, Kumar S, Mishra R. Shelterin complex gene: Prognosis and therapeutic vulnerability in cancer. Biochem Biophys Rep 2021;26:100937. [PMID: 33553693 DOI: 10.1016/j.bbrep.2021.100937] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Takakura M, Takata E, Sasagawa T. A Novel Liquid Biopsy Strategy to Detect Small Amounts of Cancer Cells Using Cancer-Specific Replication Adenoviruses. J Clin Med 2020;9:E4044. [PMID: 33327605 DOI: 10.3390/jcm9124044] [Reference Citation Analysis]
45 Aubert G. Telomere Dynamics and Aging. Telomeres in Health and Disease. Elsevier; 2014. pp. 89-111. [DOI: 10.1016/b978-0-12-397898-1.00004-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
46 Schrader M, Müller M, Heicappell R, Krause H, Schulze W, Miller K. Telomerase activity and expression of telomerase subunits in the testicular tissue of infertile patients. Fertility and Sterility 2000;73:706-11. [DOI: 10.1016/s0015-0282(99)00603-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Yang XY, Kimura M, Jeanclos E, Aviv A. Cellular proliferation and telomerase activity in CHRF-288-11 cells. Life Sci. 2000;66:1545-1555. [PMID: 10794502 DOI: 10.1016/s0024-3205(00)00472-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
48 Ogretmen B, Schady D, Usta J, Wood R, Kraveka JM, Luberto C, Birbes H, Hannun YA, Obeid LM. Role of ceramide in mediating the inhibition of telomerase activity in A549 human lung adenocarcinoma cells. J Biol Chem. 2001;276:24901-24910. [PMID: 11335714 DOI: 10.1074/jbc.m100314200] [Cited by in Crossref: 85] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
49 Gardano L, Holland L, Oulton R, Le Bihan T, Harrington L. Native gel electrophoresis of human telomerase distinguishes active complexes with or without dyskerin. Nucleic Acids Res 2012;40:e36. [PMID: 22187156 DOI: 10.1093/nar/gkr1243] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
50 Cong YS, Wright WE, Shay JW. Human telomerase and its regulation. Microbiol Mol Biol Rev. 2002;66:407-425, table of contents. [PMID: 12208997 DOI: 10.1128/mmbr.66.3.407-425.2002] [Cited by in Crossref: 549] [Cited by in F6Publishing: 225] [Article Influence: 27.5] [Reference Citation Analysis]
51 Zhang R, Wang X, Guo L, Xie H. Growth inhibition of BEL-7404 human hepatoma cells by expression of mutant telomerase reverse transcriptase. Int J Cancer. 2002;97:173-179. [PMID: 11774261 DOI: 10.1002/ijc.1597] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
52 Yajima T, Yagihashi A, Kameshima H, Kobayashi D, Furuya D, Hirata K, Watanabe N. Quantitative reverse transcription-PCR assay of the RNA component of human telomerase using the TaqMan fluorogenic detection system. Clinical Chemistry 1998;44:2441-5. [DOI: 10.1093/clinchem/44.12.2441] [Cited by in Crossref: 69] [Cited by in F6Publishing: 44] [Article Influence: 2.9] [Reference Citation Analysis]
53 Sun XC, Yan JY, Chen XL, Huang YP, Shen X, Ye XH. Depletion of telomerase RNA inhibits growth of gastrointestinal tumors transplanted in mice. World J Gastroenterol 2013; 19(15): 2340-2347 [PMID: 23613627 DOI: 10.3748/wjg.v19.i15.2340] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
54 Nakanishi K, Kawai T, Kumaki F, Hirot S, Mukai M, Ikeda E. Expression of human telomerase RNA component and telomerase reverse transcriptase mRNA in atypical adenomatous hyperplasia of the lung. Hum Pathol 2002;33:697-702. [PMID: 12196920 DOI: 10.1053/hupa.2002.125775] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
55 Ascenzioni F, Donini P, Lipps HJ. Mammalian artificial chromosomes-vectors for somatic gene therapy. Cancer Lett. 1997;118:135-142. [PMID: 9459203 DOI: 10.1016/S0304-3835(97)00323-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
56 Collins K, Mitchell JR. Telomerase in the human organism. Oncogene. 2002;21:564-579. [PMID: 11850781 DOI: 10.1038/sj.onc.1205083] [Cited by in Crossref: 414] [Cited by in F6Publishing: 378] [Article Influence: 20.7] [Reference Citation Analysis]
57 Dwyer J, Li H, Xu D, Liu JP. Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family. Ann N Y Acad Sci. 2007;1114:36-47. [PMID: 17986575 DOI: 10.1196/annals.1396.022] [Cited by in Crossref: 60] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
58 Rebaї M, Rebaї A. Molecular genetics of thyroid cancer. Genet Res (Camb) 2016;98:e7. [PMID: 27174043 DOI: 10.1017/S0016672316000057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
59 Lusing AJ. The identification of telomerase subunits: catalysing telomere research. Trends Cell Biol 1997;7:299-302. [PMID: 17708963 DOI: 10.1016/S0962-8924(97)01110-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
60 Kanaya T, Kyo S, Takakura M, Ito H, Namiki M, Inoue M. hTERT is a critical determinant of telomerase activity in renal-cell carcinoma. Int J Cancer 1998;78:539-43. [DOI: 10.1002/(sici)1097-0215(19981123)78:5<539::aid-ijc2>3.0.co;2-i] [Cited by in Crossref: 77] [Cited by in F6Publishing: 23] [Article Influence: 3.2] [Reference Citation Analysis]
61 Kang SS, Kwon T, Kwon DY, Do SI. Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem. 1999;274:13085-13090. [PMID: 10224060 DOI: 10.1074/jbc.274.19.13085] [Cited by in Crossref: 334] [Cited by in F6Publishing: 308] [Article Influence: 14.5] [Reference Citation Analysis]
62 Cerni C. Telomeres, telomerase, and myc. An update. Mutat Res. 2000;462:31-47. [PMID: 10648922 DOI: 10.1016/s1383-5742(99)00091-5] [Cited by in Crossref: 102] [Cited by in F6Publishing: 26] [Article Influence: 4.6] [Reference Citation Analysis]
63 Kirkpatrick KL, Ogunkolade W, Elkak AE, Bustin S, Jenkins P, Ghilchick M, Newbold RF, Mokbel K. hTERT expression in human breast cancer and non-cancerous breast tissue: correlation with tumour stage and c-Myc expression. Breast Cancer Res Treat 2003;77:277-84. [PMID: 12602927 DOI: 10.1023/a:1021849217054] [Cited by in Crossref: 32] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
64 Yang J, Nagasawa DT, Spasic M, Amolis M, Choy W, Garcia HM, Prins RM, Liau LM, Yang I. Endogenous Vaults and Bioengineered Vault Nanoparticles for Treatment of Glioblastomas. Neurosurgery Clinics of North America 2012;23:451-8. [DOI: 10.1016/j.nec.2012.04.012] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
65 Beattie TL, Zhou W, Robinson MO, Harrington L. Polymerization defects within human telomerase are distinct from telomerase RNA and TEP1 binding. Mol Biol Cell 2000;11:3329-40. [PMID: 11029039 DOI: 10.1091/mbc.11.10.3329] [Cited by in Crossref: 61] [Cited by in F6Publishing: 67] [Article Influence: 2.8] [Reference Citation Analysis]
66 Nakano M, Kakiuchi Y, Shimada Y, Ohyama M, Ogiwara Y, Sasaki-higashiyama N, Yano N, Ikeda F, Yamada E, Iwamatsu A, Kobayashi K, Nishiyama K, Ichikawa S, Kaji K, Ide T, Murofushi H, Murakami-murofushi K. MOV10 as a novel telomerase-associated protein. Biochemical and Biophysical Research Communications 2009;388:328-32. [DOI: 10.1016/j.bbrc.2009.08.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
67 Li H, Zhao L, Yang Z, Funder JW, Liu J. Telomerase Is Controlled by Protein Kinase Cα in Human Breast Cancer Cells. Journal of Biological Chemistry 1998;273:33436-42. [DOI: 10.1074/jbc.273.50.33436] [Cited by in Crossref: 144] [Cited by in F6Publishing: 131] [Article Influence: 6.0] [Reference Citation Analysis]
68 Kondo Y, Kondo S. Telomerase RNA inhibition using antisense oligonucleotide against human telomerase RNA linked to a 2',5'-oligoadenylate. Methods Mol Biol 2007;405:97-112. [PMID: 18369820 DOI: 10.1007/978-1-60327-070-0_9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
69 Sato N, Mizumoto K, Kusumoto M, Nishio S, Maehara N, Urashima T, Ogawa T, Tanaka M. Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide. Br J Cancer 2000;82:1819-26. [PMID: 10839297 DOI: 10.1054/bjoc.2000.1117] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
70 Eller MS, Puri N, Hadshiew IM, Venna SS, Gilchrest BA. Induction of apoptosis by telomere 3' overhang-specific DNA. Exp Cell Res 2002;276:185-93. [PMID: 12027448 DOI: 10.1006/excr.2002.5531] [Cited by in Crossref: 59] [Cited by in F6Publishing: 56] [Article Influence: 3.0] [Reference Citation Analysis]
71 Gowan SM, Heald R, Stevens MF, Kelland LR. Potent inhibition of telomerase by small-molecule pentacyclic acridines capable of interacting with G-quadruplexes. Mol Pharmacol 2001;60:981-8. [PMID: 11641426 DOI: 10.1124/mol.60.5.981] [Cited by in Crossref: 154] [Cited by in F6Publishing: 141] [Article Influence: 7.3] [Reference Citation Analysis]
72 Yatabe N, Kyo S, Kondo S, Kanaya T, Wang Z, Maida Y, Takakura M, Nakamura M, Tanaka M, Inoue M. 2-5A antisense therapy directed against human telomerase RNA inhibits telomerase activity and induces apoptosis without telomere impairment in cervical cancer cells. Cancer Gene Ther. 2002;9:624-630. [PMID: 12082463 DOI: 10.1038/sj.cgt.7700479] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.5] [Reference Citation Analysis]
73 Ahmed S, Sheng H, Niu L, Henderson E. Tetrahymena Mutants With Short Telomeres. Genetics 1998;150:643-50. [DOI: 10.1093/genetics/150.2.643] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
74 Sipos F, Galamb O, Herszényi L, Molnár B, Solymosi N, Zágoni T, Berczi L, Tulassay Z. Elevated insulin-like growth factor 1 receptor, hepatocyte growth factor receptor and telomerase protein expression in mild ulcerative colitis. Scand J Gastroenterol. 2008;43:289-298. [PMID: 18938767 DOI: 10.1080/00365520701714434] [Cited by in Crossref: 14] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
75 Niu H, Xia J, Lue NF. Characterization of the interaction between the nuclease and reverse transcriptase activity of the yeast telomerase complex. Mol Cell Biol 2000;20:6806-15. [PMID: 10958677 DOI: 10.1128/MCB.20.18.6806-6815.2000] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.0] [Reference Citation Analysis]
76 Bravaccini S, Sanchini MA, Amadori A, Medri L, Saragoni L, Calistri D, Monti F, Volpi A, Amadori D. Potential of telomerase expression and activity in cervical specimens as a diagnostic tool. J Clin Pathol 2005;58:911-4. [PMID: 16126869 DOI: 10.1136/jcp.2004.024158] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
77 Liu J. Studies of the molecular mechanisms in the regulation of telomerase activity. FASEB j 1999;13:2091-104. [DOI: 10.1096/fasebj.13.15.2091] [Cited by in Crossref: 173] [Cited by in F6Publishing: 165] [Article Influence: 7.5] [Reference Citation Analysis]
78 Stynen B, Tournu H, Tavernier J, Van Dijck P. Diversity in genetic in vivo methods for protein-protein interaction studies: from the yeast two-hybrid system to the mammalian split-luciferase system. Microbiol Mol Biol Rev 2012;76:331-82. [PMID: 22688816 DOI: 10.1128/MMBR.05021-11] [Cited by in Crossref: 133] [Cited by in F6Publishing: 55] [Article Influence: 13.3] [Reference Citation Analysis]
79 Ford LP, Shay JW, Wright WE. The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo. RNA 2001;7:1068-75. [PMID: 11497426 DOI: 10.1017/s1355838201010159] [Cited by in Crossref: 29] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
80 Chai W, Ford LP, Lenertz L, Wright WE, Shay JW. Human Ku70/80 associates physically with telomerase through interaction with hTERT. J Biol Chem 2002;277:47242-7. [PMID: 12377759 DOI: 10.1074/jbc.M208542200] [Cited by in Crossref: 86] [Cited by in F6Publishing: 49] [Article Influence: 4.3] [Reference Citation Analysis]
81 Zhou X, Chen S, Liu D, Wang Y, Xiao B, Tao Z. Short hairpin ribonucleic acid targeting the telomerase catalytic unit of messenger ribonucleic acid significantly limits the growth of laryngeal squamous cell carcinoma in nude mice. J Laryngol Otol 2008;122:513-21. [DOI: 10.1017/s0022215107008882] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
82 Yuan X, Ishibashi S, Hatakeyama S, Saito M, Nakayama J, Nikaido R, Haruyama T, Watanabe Y, Iwata H, Iida M, Sugimura H, Yamada N, Ishikawa F. Presence of telomeric G-strand tails in the telomerase catalytic subunit TERT knockout mice: TERT knockout mice. Genes to Cells 1999;4:563-72. [DOI: 10.1046/j.1365-2443.1999.00284.x] [Cited by in Crossref: 77] [Cited by in F6Publishing: 67] [Article Influence: 3.7] [Reference Citation Analysis]
83 Drees BL. Progress and variations in two-hybrid and three-hybrid technologies. Current Opinion in Chemical Biology 1999;3:64-70. [DOI: 10.1016/s1367-5931(99)80012-x] [Cited by in Crossref: 55] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
84 Crowe DL, Nguyen DC. Rb and E2F-1 regulate telomerase activity in human cancer cells. Biochim Biophys Acta 2001;1518:1-6. [PMID: 11267653 DOI: 10.1016/s0167-4781(00)00296-7] [Cited by in Crossref: 27] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
85 Arai J, Yasukawa M, Ohminami H, Kakimoto M, Hasegawa A, Fujita S. Identification of human telomerase reversetranscriptase-derived peptides that induce HLA-A24-restricted antileukemia cytotoxic T lymphocytes. Blood. 2001;97:2903-2907. [PMID: 11313288 DOI: 10.1182/blood.V97.9.2903] [Cited by in Crossref: 82] [Cited by in F6Publishing: 27] [Article Influence: 3.9] [Reference Citation Analysis]
86 Majerská J, Schrumpfová PP, Dokládal L, Schořová Š, Stejskal K, Obořil M, Honys D, Kozáková L, Polanská PS, Sýkorová E. Tandem affinity purification of AtTERT reveals putative interaction partners of plant telomerase in vivo. Protoplasma 2017;254:1547-62. [PMID: 27853871 DOI: 10.1007/s00709-016-1042-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
87 Bachand F, Boisvert FM, Côté J, Richard S, Autexier C. The product of the survival of motor neuron (SMN) gene is a human telomerase-associated protein. Mol Biol Cell 2002;13:3192-202. [PMID: 12221125 DOI: 10.1091/mbc.e02-04-0216] [Cited by in Crossref: 44] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
88 Lin Z, Lim S, Viani MA, Sapp M, Lim MS. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents. Am J Pathol 2001;159:711-9. [PMID: 11485929 DOI: 10.1016/S0002-9440(10)61742-7] [Cited by in Crossref: 40] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
89 Saldanha SN, Andrews LG, Tollefsbol TO. Analysis of telomerase activity and detection of its catalytic subunit, hTERT. Anal Biochem 2003;315:1-21. [PMID: 12672407 DOI: 10.1016/s0003-2697(02)00663-2] [Cited by in Crossref: 57] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
90 Aigner S, Lingner J, Goodrich KJ, Grosshans CA, Shevchenko A, Mann M, Cech TR. Euplotes telomerase contains an La motif protein produced by apparent translational frameshifting. EMBO J 2000;19:6230-9. [PMID: 11080168 DOI: 10.1093/emboj/19.22.6230] [Cited by in Crossref: 57] [Cited by in F6Publishing: 67] [Article Influence: 2.7] [Reference Citation Analysis]
91 Kim CH, Cheong JH, Bak KH, Kim JM, Oh SJ. Prognostic implication of telomerase activity in patients with brain tumors. J Korean Med Sci 2006;21:126-30. [PMID: 16479078 DOI: 10.3346/jkms.2006.21.1.126] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
92 Reddel RR. Genes involved in the control of cellular proliferative potential. Ann N Y Acad Sci. 1998;854:8-19. [PMID: 9928415 DOI: 10.1111/j.1749-6632.1998.tb09887.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
93 Zhu J, Zhao Y, Wang S. Chromatin and epigenetic regulation of the telomerase reverse transcriptase gene. Protein Cell 2010;1:22-32. [PMID: 21203995 DOI: 10.1007/s13238-010-0014-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 4.6] [Reference Citation Analysis]
94 Sabah M, Cummins R, Leader M, Kay E. Immunohistochemical Detection of hTERT Protein in Soft Tissue Sarcomas: Correlation With Tumor Grade. Applied Immunohistochemistry & Molecular Morphology 2006;14:198-202. [DOI: 10.1097/01.pai.0000156606.04726.d3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
95 Robinson MO. Telomerase and cancer. Genet Eng (N Y) 2000;22:209-22. [PMID: 11501378 DOI: 10.1007/978-1-4615-4199-8_12] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
96 Sun P, Wei L, Luo M, Liu G, Wang J, Mustea A, Könsgen D, Lichtenegger W, Sehouli J. The telomerase activity and expression of hTERT gene can serve as indicators in the anti-cancer treatment of human ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 2007;130:249-57. [DOI: 10.1016/j.ejogrb.2006.01.028] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
97 Roy J, Fulton TB, Blackburn EH. Specific telomerase RNA residues distant from the template are essential for telomerase function. Genes Dev 1998;12:3286-300. [PMID: 9784502 DOI: 10.1101/gad.12.20.3286] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 2.2] [Reference Citation Analysis]
98 Lo YMD. Quantitative Assays for Telomerase: Means for Studying the End. Clinical Chemistry 1998;44:2399-400. [DOI: 10.1093/clinchem/44.12.2399] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
99 Erlitzki R, Minuk GY. Telomeres, telomerase and HCC: the long and the short of it. J Hepatol. 1999;31:939-945. [PMID: 10580594 DOI: 10.1016/s0168-8278(99)80298-0] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
100 Dome JS, Look AT. Three molecular determinants of malignant conversion and their potential as therapeutic targets: . Current Opinion in Oncology 1999;11:58. [DOI: 10.1097/00001622-199901000-00013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
101 Kelland LR. Telomerase inhibitors: targeting the vulnerable end of cancer? Anticancer Drugs 2000;11:503-13. [PMID: 11036953 DOI: 10.1097/00001813-200008000-00001] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.6] [Reference Citation Analysis]
102 Mathew R, Jia W, Sharma A, Zhao Y, Clarke LE, Cheng X, Wang H, Salli U, Vrana KE, Robertson GP, Zhu J, Wang S. Robust activation of the human but not mouse telomerase gene during the induction of pluripotency. FASEB J 2010;24:2702-15. [PMID: 20354136 DOI: 10.1096/fj.09-148973] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 3.3] [Reference Citation Analysis]
103 Nguyen DC, Crowe DL. Intact functional domains of the retinoblastoma gene product (pRb) are required for downregulation of telomerase activity. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 1999;1445:207-15. [DOI: 10.1016/s0167-4781(99)00044-5] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
104 Jia W, Wang S, Horner JW, Wang N, Wang H, Gunther EJ, DePinho RA, Zhu J. A BAC transgenic reporter recapitulates in vivo regulation of human telomerase reverse transcriptase in development and tumorigenesis. FASEB J 2011;25:979-89. [PMID: 21135040 DOI: 10.1096/fj.10-173989] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
105 Colgin LM, Reddel RR. Telomere maintenance mechanisms and cellular immortalization. Curr Opin Genet Dev 1999;9:97-103. [PMID: 10072358 DOI: 10.1016/s0959-437x(99)80014-8] [Cited by in Crossref: 118] [Cited by in F6Publishing: 40] [Article Influence: 5.1] [Reference Citation Analysis]
106 van Zon A, Mossink MH, Schoester M, Houtsmuller AB, Scheffer GL, Scheper RJ, Sonneveld P, Wiemer EAC. The formation of vault-tubes: a dynamic interaction between vaults and vault PARP. Journal of Cell Science 2003;116:4391-400. [DOI: 10.1242/jcs.00749] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
107 Beattie TL, Zhou W, Robinson MO, Harrington L. Reconstitution of human telomerase activity in vitro. Curr Biol. 1998;8:177-180. [PMID: 9443919 DOI: 10.1016/s0960-9822(98)70067-3] [Cited by in Crossref: 223] [Cited by in F6Publishing: 117] [Article Influence: 9.3] [Reference Citation Analysis]
108 Eitsuka T, Nakagawa K, Miyazawa T. Down-regulation of telomerase activity in DLD-1 human colorectal adenocarcinoma cells by tocotrienol. Biochem Biophys Res Commun 2006;348:170-5. [PMID: 16875674 DOI: 10.1016/j.bbrc.2006.07.029] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
109 Harada K, Yasoshima M, Ozaki S, Sanzen T, Nakanuma Y. PCR and in situ hybridization studies of telomerase subunits in human non-neoplastic livers. J Pathol 2001;193:210-7. [PMID: 11180168 DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH786>3.0.CO;2-G] [Cited by in Crossref: 18] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
110 Li H, Zhao L, Funder JW, Liu J. Protein Phosphatase 2A Inhibits Nuclear Telomerase Activity in Human Breast Cancer Cells. Journal of Biological Chemistry 1997;272:16729-32. [DOI: 10.1074/jbc.272.27.16729] [Cited by in Crossref: 131] [Cited by in F6Publishing: 125] [Article Influence: 5.2] [Reference Citation Analysis]
111 Aldous WK, Marean AJ, Dehart MJ, Matej LA, Moore KH. Effects of tamoxifen on telomerase activity in breast carcinoma cell lines. Cancer 1999;85:1523-9. [DOI: 10.1002/(sici)1097-0142(19990401)85:7<1523::aid-cncr13>3.0.co;2-p] [Cited by in Crossref: 36] [Article Influence: 1.6] [Reference Citation Analysis]
112 Yaswen P, MacKenzie KL, Keith WN, Hentosh P, Rodier F, Zhu J, Firestone GL, Matheu A, Carnero A, Bilsland A, Sundin T, Honoki K, Fujii H, Georgakilas AG, Amedei A, Amin A, Helferich B, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Bhakta D, Halicka D, Niccolai E, Aquilano K, Ashraf SS, Nowsheen S, Yang X. Therapeutic targeting of replicative immortality. Semin Cancer Biol 2015;35 Suppl:S104-28. [PMID: 25869441 DOI: 10.1016/j.semcancer.2015.03.007] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
113 Mokbel K. The role of telomerase in breast cancer. European Journal of Surgical Oncology (EJSO) 2000;26:509-14. [DOI: 10.1053/ejso.1999.0932] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
114 Muzza M, Colombo C, Rossi S, Tosi D, Cirello V, Perrino M, De Leo S, Magnani E, Pignatti E, Vigo B, Simoni M, Bulfamante G, Vicentini L, Fugazzola L. Telomerase in differentiated thyroid cancer: promoter mutations, expression and localization. Mol Cell Endocrinol 2015;399:288-95. [PMID: 25448848 DOI: 10.1016/j.mce.2014.10.019] [Cited by in Crossref: 75] [Cited by in F6Publishing: 75] [Article Influence: 9.4] [Reference Citation Analysis]
115 Lue NF, Xia J. Species-specific and sequence-specific recognition of the dG-rich strand of telomeres by yeast telomerase. Nucleic Acids Res 1998;26:1495-502. [PMID: 9490797 DOI: 10.1093/nar/26.6.1495] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 0.5] [Reference Citation Analysis]
116 Yan P, Saraga EP, Bouzourene H, Bosman FT, Benhattar J. Expression of telomerase genes correlates with telomerase activity in human colorectal carcinogenesis. J Pathol 2001;193:21-6. [PMID: 11169511 DOI: 10.1002/1096-9896(2000)9999:9999<::AID-PATH728>3.0.CO;2-G] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
117 Liu JP, Cassar L, Pinto A, Li H. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma. Cell Res 2006;16:809-17. [PMID: 17016469 DOI: 10.1038/sj.cr.7310098] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
118 Hiyama E, Hiyama K, Yokoyama T, Shay JW. Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001;3:17-26. [PMID: 11326312 DOI: 10.1038/sj.neo.7900134] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 5.1] [Reference Citation Analysis]
119 Raymond E, Sun D, Izbicka E, Mangold G, Silvas E, Windle B, Sharma S, Soda H, Laurence R, Davidson K, Von Hoff DD. A human breast cancer model for the study of telomerase inhibitors based on a new biotinylated-primer extension assay. Br J Cancer 1999;80:1332-41. [PMID: 10424733 DOI: 10.1038/sj.bjc.6690526] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
120 Shin KH, Kang MK, Dicterow E, Park NH. Hypermethylation of the hTERT promoter inhibits the expression of telomerase activity in normal oral fibroblasts and senescent normal oral keratinocytes. Br J Cancer 2003;89:1473-8. [PMID: 14562019 DOI: 10.1038/sj.bjc.6601291] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 2.5] [Reference Citation Analysis]
121 Ye AJ, Haynes WJ, Romero DP. Expression of mutated Paramecium telomerase RNAs in vivo leads to templating errors that resemble those made by retroviral reverse transcriptase. Mol Cell Biol 1999;19:2887-94. [PMID: 10082555 DOI: 10.1128/MCB.19.4.2887] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
122 Kasiappan R, Shen Z, Tse AK, Jinwal U, Tang J, Lungchukiet P, Sun Y, Kruk P, Nicosia SV, Zhang X, Bai W. 1,25-Dihydroxyvitamin D3 suppresses telomerase expression and human cancer growth through microRNA-498. J Biol Chem 2012;287:41297-309. [PMID: 23055531 DOI: 10.1074/jbc.M112.407189] [Cited by in Crossref: 86] [Cited by in F6Publishing: 51] [Article Influence: 8.6] [Reference Citation Analysis]
123 Fujiwara T. Telomerase-specific virotherapy for human squamous cell carcinoma. Expert Opin Biol Ther. 2009;9:321-329. [PMID: 19216621 DOI: 10.1517/14712590802715731] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
124 Elkak AE, Meligonis G, Salhab M, Mitchell B, Blake JR, Newbold RF, Mokbel K. hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer. J Carcinog 2005;4:17. [PMID: 16202165 DOI: 10.1186/1477-3163-4-17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
125 Xia J, Peng Y, Mian IS, Lue NF. Identification of functionally important domains in the N-terminal region of telomerase reverse transcriptase. Mol Cell Biol 2000;20:5196-207. [PMID: 10866675 DOI: 10.1128/MCB.20.14.5196-5207.2000] [Cited by in Crossref: 104] [Cited by in F6Publishing: 62] [Article Influence: 4.7] [Reference Citation Analysis]
126 Bryan TM, Sperger JM, Chapman KB, Cech TR. Telomerase reverse transcriptase genes identified in Tetrahymena thermophila and Oxytricha trifallax. Proc Natl Acad Sci U S A 1998;95:8479-84. [PMID: 9671703 DOI: 10.1073/pnas.95.15.8479] [Cited by in Crossref: 95] [Cited by in F6Publishing: 99] [Article Influence: 4.0] [Reference Citation Analysis]
127 Yang SM, Fang DC, Yang JL, Liang GP, Lu R, Luo YH, Liu WW. Effect of antisense human telomerase RNA onmalignant phenotypes of gastric carcinoma. J Gastroenterol Hepatol. 2002;17:1144-1152. [PMID: 12453272 DOI: 10.1046/j.1440-1746.2002.02857.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
128 Saito T, Matsuda Y, Suzuki T, Hayashi A, Yuan X, Saito M, Nakayama J, Hori T, Ishikawa F. Comparative gene mapping of the human and mouse TEP1 genes, which encode one protein component of telomerases. Genomics. 1997;46:46-50. [PMID: 9403057 DOI: 10.1006/geno.1997.5005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
129 Jordan C, Li HH, Kwan HC, Francke U. Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets. BMC Med Genet 2007;8:36. [PMID: 17584923 DOI: 10.1186/1471-2350-8-36] [Cited by in Crossref: 86] [Cited by in F6Publishing: 92] [Article Influence: 5.7] [Reference Citation Analysis]
130 Singh SM, Steinberg-Neifach O, Mian IS, Lue NF. Analysis of telomerase in Candida albicans: potential role in telomere end protection. Eukaryot Cell 2002;1:967-77. [PMID: 12477797 DOI: 10.1128/EC.1.6.967-977.2002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
131 Zhang B, Kraemer B, SenGupta D, Fields S, Wickens M. Yeast three-hybrid system to detect and analyze RNA-protein interactions. Methods Enzymol 2000;318:399-419. [PMID: 10890002 DOI: 10.1016/s0076-6879(00)18066-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
132 Uchida N, Tsutsui K, Ezaki T, Fukuma H, Kobara H, Kamata H, Aritomo Y, Masaki T, Watanabe S, Kobayashi S, Nakatsu T, Nakano H, Kuriyama S. Combination of assay of human telomerase reverse transcriptase mRNA and cytology using bile obtained by endoscopic transpapillary catheterization into the gallbladder for diagnosis of gallbladder carcinoma. Am J Gastroenterology 2003;98:2415-9. [DOI: 10.1111/j.1572-0241.2003.07693.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
133 Fujiwara T. Targeted Oncolytic Adenovirus for Human Cancer Therapy: Gene-Based Therapies for Cancer. In: Roth JA, editor. Gene-Based Therapies for Cancer. New York: Springer; 2010. pp. 79-93. [DOI: 10.1007/978-1-4419-6102-0_6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
134 Brümmendorf TH, Lansdorp PM, Rufer N. Telomere Length Dynamics in Normal and Malignant Hematopoiesis. Journal of Anti-Aging Medicine 2000;3:397-409. [DOI: 10.1089/rej.1.2000.3.397] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
135 Jin D, Kim S, Kim D, Park J. Two genetic variants in telomerase-associated protein 1 are associated with stomach cancer risk. J Hum Genet 2016;61:885-9. [DOI: 10.1038/jhg.2016.71] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
136 Martín-Rivera L, Herrera E, Albar JP, Blasco MA. Expression of mouse telomerase catalytic subunit in embryos and adult tissues. Proc Natl Acad Sci USA. 1998;95:10471-10476. [PMID: 9724727 DOI: 10.1073/pnas.95.18.10471] [Cited by in Crossref: 152] [Cited by in F6Publishing: 159] [Article Influence: 6.3] [Reference Citation Analysis]
137 Herrera E, Samper E, Martín-Caballero J, Flores JM, Lee HW, Blasco MA. Disease states associated with telomerase deficiency appear earlier in mice with short telomeres. EMBO J 1999;18:2950-60. [PMID: 10357808 DOI: 10.1093/emboj/18.11.2950] [Cited by in Crossref: 328] [Cited by in F6Publishing: 316] [Article Influence: 14.3] [Reference Citation Analysis]
138 Fan X, Wang Y, Kratz J, Brat DJ, Robitaille Y, Moghrabi A, Perlman EJ, Dang CV, Burger PC, Eberhart CG. hTERT gene amplification and increased mRNA expression in central nervous system embryonal tumors. Am J Pathol 2003;162:1763-9. [PMID: 12759234 DOI: 10.1016/S0002-9440(10)64311-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
139 Cano MI, Blake JJ, Blackburn EH, Agabian N. A Trypanosoma brucei protein complex that binds G-overhangs and co-purifies with telomerase activity. J Biol Chem 2002;277:896-906. [PMID: 11673453 DOI: 10.1074/jbc.M104111200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
140 Krams M, Claviez A, Heidorn K, Krupp G, Parwaresch R, Harms D, Rudolph P. Regulation of telomerase activity by alternate splicing of human telomerase reverse transcriptase mRNA in a subset of neuroblastomas. Am J Pathol 2001;159:1925-32. [PMID: 11696453 DOI: 10.1016/S0002-9440(10)63039-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
141 Engelberg H. Actions of heparin that may affect the malignant process. Cancer 1999;85:257-72. [DOI: 10.1002/(sici)1097-0142(19990115)85:2<257::aid-cncr1>3.0.co;2-2] [Cited by in Crossref: 81] [Cited by in F6Publishing: 28] [Article Influence: 3.5] [Reference Citation Analysis]
142 Perry PJ, Kelland LR. Telomeres and telomerase: targets for cancer chemotherapy? Expert Opinion on Therapeutic Patents 2005;8:1567-86. [DOI: 10.1517/13543776.8.12.1567] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
143 Kim E, Kim J, Shin H, Lee H, Yang JM, Kim J, Sohn J, Kim H, Yun C. Ad-mTERT-Δ19, a Conditional Replication-Competent Adenovirus Driven by the Human Telomerase Promoter, Selectively Replicates in and Elicits Cytopathic Effect in a Cancer Cell-Specific Manner. Human Gene Therapy 2003;14:1415-28. [DOI: 10.1089/104303403769211637] [Cited by in Crossref: 87] [Cited by in F6Publishing: 72] [Article Influence: 4.6] [Reference Citation Analysis]
144 Bantis A, Patsouris E, Gonidi M, Kavantzas N, Tsipis A, Athanassiadou A, Aggelonidou E, Athanassiadou P. Telomerase RNA Expression and DNA Ploidy as Prognostic Markers of Prostate Carcinomas. Tumori 2009;95:744-52. [DOI: 10.1177/030089160909500618] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
145 Bateman A, Kickhoefer V. The TROVE module: a common element in Telomerase, Ro and Vault ribonucleoproteins. BMC Bioinformatics 2003;4:49. [PMID: 14563212 DOI: 10.1186/1471-2105-4-49] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
146 Sabah M, Cummins R, Leader M, Kay E. Expression of human telomerase reverse transcriptase in gastrointestinal stromal tumors occurs preferentially in malignant neoplasms. Human Pathology 2004;35:1231-5. [DOI: 10.1016/j.humpath.2004.07.010] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
147 Deshpande R, Sharma S, Verfaillie CM, Hu WS, Myers CL. A scalable approach for discovering conserved active subnetworks across species. PLoS Comput Biol 2010;6:e1001028. [PMID: 21170309 DOI: 10.1371/journal.pcbi.1001028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
148 Shao JC, Wu JF, Wang DB, Qin R, Zhang H. Relationship between the expression of human telomerase reverse transcriptase gene and cell cycle regulators in gastric cancer and its significance. World J Gastroenterol 2003; 9(3): 427-431 [PMID: 12632490 DOI: 10.3748/wjg.v9.i3.427] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
149 Xiong J, Fan S, Meng Q, Schramm L, Wang C, Bouzahza B, Zhou J, Zafonte B, Goldberg ID, Haddad BR, Pestell RG, Rosen EM. BRCA1 inhibition of telomerase activity in cultured cells. Mol Cell Biol 2003;23:8668-90. [PMID: 14612409 DOI: 10.1128/MCB.23.23.8668-8690.2003] [Cited by in Crossref: 61] [Cited by in F6Publishing: 32] [Article Influence: 3.2] [Reference Citation Analysis]
150 Gnanasekar M, Thirugnanam S, Zheng G, Chen A, Ramaswamy K. T-oligo induces apoptosis in advanced prostate cancer cells. Oligonucleotides 2009;19:287-92. [PMID: 19642913 DOI: 10.1089/oli.2009.0179] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
151 Shore D. Telomerase and telomere-binding proteins: controlling the endgame. Trends Biochem Sci 1997;22:233-5. [PMID: 9255061 DOI: 10.1016/s0968-0004(97)01082-7] [Cited by in Crossref: 41] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
152 Holt SE, Aisner DL, Baur J, Tesmer VM, Dy M, Ouellette M, Trager JB, Morin GB, Toft DO, Shay JW. Functional requirement of p23 and Hsp90 in telomerase complexes. Genes Dev. 1999;13:817-826. [PMID: 10197982 DOI: 10.1101/gad.13.7.817] [Cited by in Crossref: 366] [Cited by in F6Publishing: 360] [Article Influence: 15.9] [Reference Citation Analysis]
153 González-Suárez E, Samper E, Ramírez A, Flores JM, Martín-Caballero J, Jorcano JL, Blasco MA. Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes. EMBO J 2001;20:2619-30. [PMID: 11387197 DOI: 10.1093/emboj/20.11.2619] [Cited by in Crossref: 261] [Cited by in F6Publishing: 242] [Article Influence: 12.4] [Reference Citation Analysis]
154 Liu W, Jiang J, Xiao D, Ding J. Down-regulation of telomerase activity via protein phosphatase 2A activation in salvicine-induced human leukemia HL-60 cell apoptosis. Biochemical Pharmacology 2002;64:1677-87. [DOI: 10.1016/s0006-2952(02)01424-7] [Cited by in Crossref: 34] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
155 Lue NF, Peng Y. Negative regulation of yeast telomerase activity through an interaction with an upstream region of the DNA primer. Nucleic Acids Res 1998;26:1487-94. [PMID: 9490796 DOI: 10.1093/nar/26.6.1487] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.4] [Reference Citation Analysis]
156 Chen X, Wolin SL. The Ro 60 kDa autoantigen: insights into cellular function and role in autoimmunity. J Mol Med (Berl). 2004;82:232-239. [PMID: 15168680 DOI: 10.1007/s00109-004-0529-0] [Cited by in Crossref: 63] [Cited by in F6Publishing: 62] [Article Influence: 3.5] [Reference Citation Analysis]
157 Weng NP, Hathcock KS, Hodes RJ. Regulation of telomere length and telomerase in T and B cells: a mechanism for maintaining replicative potential. Immunity 1998;9:151-7. [PMID: 9729035 DOI: 10.1016/s1074-7613(00)80597-x] [Cited by in Crossref: 120] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
158 Urquidi V, Tarin D, Goodison S. Telomerase in cancer: Clinical applications. Annals of Medicine 2009;30:419-30. [DOI: 10.3109/07853899809002483] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
159 Kraemer B, Zhang B, Sengupta D, Fields S, Wickens M. [19] Using the yeast three-hybrid system to detect and analyze RNA-protein interactions. Applications of Chimeric Genes and Hybrid Proteins - Part C: Protein-Protein Interactions and Genomics. Elsevier; 2000. pp. 297-321. [DOI: 10.1016/s0076-6879(00)28404-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
160 Melissourgos N, Kastrinakis N, Davilas I, Foukas P, Farmakis A, Lykourinas M. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker. Urology 2003;62:362-7. [DOI: 10.1016/s0090-4295(03)00254-1] [Cited by in Crossref: 45] [Cited by in F6Publishing: 4] [Article Influence: 2.4] [Reference Citation Analysis]
161 Rowley PT. Telomerase: putting an end to DNA. Cancer Invest 1998;16:170-4. [PMID: 9541631 DOI: 10.3109/07357909809050032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
162 Chen X, Zhang J, Fang Y, Zhao C, Zhu Y. Ginsenoside Rg1 delays tert-butyl hydroperoxide-induced premature senescence in human WI-38 diploid fibroblast cells. J Gerontol A Biol Sci Med Sci 2008;63:253-64. [PMID: 18375874 DOI: 10.1093/gerona/63.3.253] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
163 Armstrong L, Lako M, Lincoln J, Cairns PM, Hole N. mTert expression correlates with telomerase activity during the differentiation of murine embryonic stem cells. Mech Dev 2000;97:109-16. [PMID: 11025212 DOI: 10.1016/s0925-4773(00)00423-8] [Cited by in Crossref: 81] [Cited by in F6Publishing: 33] [Article Influence: 3.9] [Reference Citation Analysis]
164 Ghosh U, Giri K, Bhattacharyya NP. Interaction of aurintricarboxylic acid (ATA) with four nucleic acid binding proteins DNase I, RNase A, reverse transcriptase and Taq polymerase. Spectrochim Acta A Mol Biomol Spectrosc 2009;74:1145-51. [PMID: 19836295 DOI: 10.1016/j.saa.2009.09.024] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
165 Holt SE, Shay JW. Role of telomerase in cellular proliferation and cancer. J Cell Physiol 1999;180:10-8. [PMID: 10362013 DOI: 10.1002/(SICI)1097-4652(199907)180:1<10::AID-JCP2>3.0.CO;2-D] [Cited by in Crossref: 145] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
166 Emre N, Raval-fernandes S, Kickhoefer VA, Rome LH. Analysis of MVP and VPARP promoters indicates a role for chromatin remodeling in the regulation of MVP. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression 2004;1678:33-46. [DOI: 10.1016/j.bbaexp.2004.01.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
167 Oh BK, Kim YJ, Park YN, Choi J, Kim KS, Park C. Quantitative assessment of hTERT mRNA expression in dysplastic nodules of HBV-related hepatocarcinogenesis. Am J Gastroenterol 2006;101:831-8. [PMID: 16494581 DOI: 10.1111/j.1572-0241.2006.00532.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
168 Nishimoto A, Miura N, Horikawa I, Kugoh H, Murakami Y, Hirohashi S, Kawasaki H, Gazdar AF, Shay JW, Barrett JC, Oshimura M. Functional evidence for a telomerase repressor gene on human chromosome 10p15.1. Oncogene 2001;20:828-35. [DOI: 10.1038/sj.onc.1204165] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.4] [Reference Citation Analysis]
169 Kolev NG, Rajan KS, Tycowski KT, Toh JY, Shi H, Lei Y, Michaeli S, Tschudi C. The vault RNA of Trypanosoma brucei plays a role in the production of trans-spliced mRNA. J Biol Chem 2019;294:15559-74. [PMID: 31439669 DOI: 10.1074/jbc.RA119.008580] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
170 Licht JD, Collins K. Telomerase RNA function in recombinant Tetrahymena telomerase. Genes Dev 1999;13:1116-25. [PMID: 10323863 DOI: 10.1101/gad.13.9.1116] [Cited by in Crossref: 52] [Cited by in F6Publishing: 65] [Article Influence: 2.3] [Reference Citation Analysis]
171 Koga S, Kondo Y, Komata T, Kondo S. Treatment of bladder cancer cells in vitro and in vivo with 2-5A antisense telomerase RNA. Gene Ther. 2001;8:654-658. [PMID: 11320413 DOI: 10.1038/sj.gt.3301449] [Cited by in Crossref: 38] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
172 Dogan F, Forsyth NR. Telomerase Regulation: A Role for Epigenetics. Cancers (Basel) 2021;13:1213. [PMID: 33802026 DOI: 10.3390/cancers13061213] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
173 Mu J, Wei LX. Telomere and telomerase in oncology. Cell Res. 2002;12:1-7. [PMID: 11942406 DOI: 10.1038/sj.cr.7290104] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 2.0] [Reference Citation Analysis]
174 Bajpai AK, Park J, Moon I, Kang H, Lee Y, Doh K, Suh S, Chang B, Park J. Rapid blockade of telomerase activity and tumor cell growth by the DPL lipofection of ribbon antisense to hTR. Oncogene 2005;24:6492-501. [DOI: 10.1038/sj.onc.1208731] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
175 Del Bufalo D, Rizzo A, Trisciuoglio D, Cardinali G, Torrisi MR, Zangemeister-Wittke U, Zupi G, Biroccio A. Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function. Cell Death Differ 2005;12:1429-38. [PMID: 15920535 DOI: 10.1038/sj.cdd.4401670] [Cited by in Crossref: 86] [Cited by in F6Publishing: 81] [Article Influence: 5.1] [Reference Citation Analysis]
176 Crea F, Sarti D, Falciani F, Al-Rubeai M. Over-expression of hTERT in CHO K1 results in decreased apoptosis and reduced serum dependency. J Biotechnol. 2006;121:109-123. [PMID: 16144725 DOI: 10.1016/j.jbiotec.2005.07.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 20] [Article Influence: 1.6] [Reference Citation Analysis]
177 Ford LP, Suh JM, Wright WE, Shay JW. Heterogeneous nuclear ribonucleoproteins C1 and C2 associate with the RNA component of human telomerase. Mol Cell Biol 2000;20:9084-91. [PMID: 11074006 DOI: 10.1128/MCB.20.23.9084-9091.2000] [Cited by in Crossref: 50] [Cited by in F6Publishing: 26] [Article Influence: 2.3] [Reference Citation Analysis]
178 Kirkpatrick KL, Mokbel K. The significance of human telomerase reverse transcriptase (hTERT) in cancer. Eur J Surg Oncol 2001;27:754-60. [PMID: 11735173 DOI: 10.1053/ejso.2001.1151] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 1.9] [Reference Citation Analysis]
179 Katakura Y, Nakata E, Miura T, Shirahata S. Transforming Growth Factor β Triggers Two Independent-Senescence Programs in Cancer Cells. Biochemical and Biophysical Research Communications 1999;255:110-5. [DOI: 10.1006/bbrc.1999.0129] [Cited by in Crossref: 80] [Cited by in F6Publishing: 80] [Article Influence: 3.5] [Reference Citation Analysis]
180 Bosoy D, Peng Y, Mian IS, Lue NF. Conserved N-terminal motifs of telomerase reverse transcriptase required for ribonucleoprotein assembly in vivo. J Biol Chem 2003;278:3882-90. [PMID: 12458198 DOI: 10.1074/jbc.M210645200] [Cited by in Crossref: 59] [Cited by in F6Publishing: 38] [Article Influence: 3.0] [Reference Citation Analysis]
181 Moriarty TJ, Huard S, Dupuis S, Autexier C. Functional multimerization of human telomerase requires an RNA interaction domain in the N terminus of the catalytic subunit. Mol Cell Biol 2002;22:1253-65. [PMID: 11809815 DOI: 10.1128/MCB.22.4.1253-1265.2002] [Cited by in Crossref: 80] [Cited by in F6Publishing: 47] [Article Influence: 4.0] [Reference Citation Analysis]
182 Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR. The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2000;2:426-32. [PMID: 11191109 DOI: 10.1038/sj.neo.7900112] [Cited by in Crossref: 153] [Cited by in F6Publishing: 143] [Article Influence: 7.3] [Reference Citation Analysis]
183 Le S, Sternglanz R, Greider CW. Identification of two RNA-binding proteins associated with human telomerase RNA. Mol Biol Cell 2000;11:999-1010. [PMID: 10712515 DOI: 10.1091/mbc.11.3.999] [Cited by in Crossref: 89] [Cited by in F6Publishing: 91] [Article Influence: 4.0] [Reference Citation Analysis]
184 Harrington L, Zhou W, McPhail T, Oulton R, Yeung DS, Mar V, Bass MB, Robinson MO. Human telomerase contains evolutionarily conserved catalytic and structural subunits. Genes Dev. 1997;11:3109-3115. [PMID: 9389643 DOI: 10.1101/gad.11.23.3109] [Cited by in Crossref: 326] [Cited by in F6Publishing: 314] [Article Influence: 13.6] [Reference Citation Analysis]
185 Fujita Y, Fujikane T, Fujiuchi S, Nishigaki Y, Yamazaki Y, Nagase A, Shimizu T, Ohsaki Y, Kikuchi K. The diagnostic and prognostic relevance of human telomerase reverse transcriptase mRNA expression detected in situ in patients with nonsmall cell lung carcinoma. Cancer 2003;98:1008-13. [PMID: 12942569 DOI: 10.1002/cncr.11611] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 1.9] [Reference Citation Analysis]
186 Uchida N, Otsuka T, Shigematsu H, Maeda M, Sugio Y, Itoh Y, Niho Y. Differential gene expression of human telomerase-associated protein hTERT and TEP1 in human hematopoietic cells. Leuk Res 1999;23:1127-32. [PMID: 10613358 DOI: 10.1016/s0145-2126(99)00149-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
187 Aubert G, Lansdorp PM. Telomeres and aging. Physiol Rev 2008;88:557-79. [PMID: 18391173 DOI: 10.1152/physrev.00026.2007] [Cited by in Crossref: 684] [Cited by in F6Publishing: 614] [Article Influence: 48.9] [Reference Citation Analysis]
188 Komata T, Kondo Y, Koga S, Ko SC, Chung LW, Kondo S. Combination therapy of malignant glioma cells with 2-5A-antisense telomerase RNA and recombinant adenovirus p53. Gene Ther. 2000;7:2071-2079. [PMID: 11223987 DOI: 10.1038/sj.gt.3301327] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.6] [Reference Citation Analysis]
189 Kong LB, Siva AC, Kickhoefer VA, Rome LH, Stewart PL. RNA location and modeling of a WD40 repeat domain within the vault. RNA 2000;6:890-900. [PMID: 10864046 DOI: 10.1017/s1355838200000157] [Cited by in Crossref: 50] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
190 Autexier C. Chapter 19 Tetrahymena Telomerase Activity, Purification, and Reconstitution. Methods in Cell Biology Volume 62. Elsevier; 1999. pp. 395-415. [DOI: 10.1016/s0091-679x(08)61545-9] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
191 Wu G, Liu D, Jiang K, Zhang L, Zeng Y, Zhou P, Zhong D, Gao M, He F, Zheng Y. PinX1, a novel target gene of p53, is suppressed by HPV16 E6 in cervical cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2014;1839:88-96. [DOI: 10.1016/j.bbagrm.2014.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
192 Siddiqui MT, Greene KL, Clark DP, Xydas S, Udelsman R, Smallridge RC, Zeiger MA, Saji M. Human telomerase reverse transcriptase expression in Diff-Quik-stained FNA samples from thyroid nodules. Diagn Mol Pathol 2001;10:123-9. [PMID: 11385322 DOI: 10.1097/00019606-200106000-00009] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
193 Kipling D. Mammalian Telomerase: Catalytic Subunit and Knockout Mice. Human Molecular Genetics 1997;6:1999-2004. [DOI: 10.1093/hmg/6.12.1999] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
194 Ye Z, Chen X, Yang S, Chen J, Xiong Y, Lu G. Expression of mouse telomerase catalytic subunit mTERT gene in testis of SD rats and its significance. J Huazhong Univ Sci Technolog Med Sci 2003;23:288-90. [PMID: 14526437 DOI: 10.1007/BF02829517] [Reference Citation Analysis]
195 Herrera E, Samper E, Blasco MA. Telomere shortening in mTR-/- embryos is associated with failure to close the neural tube. EMBO J 1999;18:1172-81. [PMID: 10064584 DOI: 10.1093/emboj/18.5.1172] [Cited by in Crossref: 104] [Cited by in F6Publishing: 97] [Article Influence: 4.5] [Reference Citation Analysis]
196 Kyo, S, Kanaya T, Takakura M, Tanaka M, Yamashita A, Inoue H, Inoue M. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors. Int J Cancer 1999;80:804-9. [DOI: 10.1002/(sici)1097-0215(19990315)80:6<804::aid-ijc2>3.0.co;2-b] [Cited by in Crossref: 58] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
197 Hahne JC, Lampis A, Valeri N. Vault RNAs: hidden gems in RNA and protein regulation. Cell Mol Life Sci 2021;78:1487-99. [PMID: 33063126 DOI: 10.1007/s00018-020-03675-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
198 Folini M, Brambilla C, Villa R, Gandellini P, Vignati S, Paduano F, Daidone MG, Zaffaroni N. Antisense oligonucleotide-mediated inhibition of hTERT, but not hTERC, induces rapid cell growth decline and apoptosis in the absence of telomere shortening in human prostate cancer cells. Eur J Cancer 2005;41:624-34. [PMID: 15737568 DOI: 10.1016/j.ejca.2004.12.002] [Cited by in Crossref: 57] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
199 Siva AC, Raval-fernandes S, Stephen AG, Lafemina MJ, Scheper RJ, Kickhoefer VA, Rome LH. Up-regulation of vaults may be necessary but not sufficient for multidrug resistance. Int J Cancer 2001;92:195-202. [DOI: 10.1002/1097-0215(200102)9999:9999<::aid-ijc1168>3.0.co;2-7] [Cited by in Crossref: 59] [Cited by in F6Publishing: 21] [Article Influence: 2.8] [Reference Citation Analysis]
200 Helder MN, Jong S, Vries EG, Zee AG. Telomerase targeting in cancer treatment: new developments. Drug Resist Updat. 1999;2:104-115. [PMID: 11504478 DOI: 10.1054/drup.1999.0074] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
201 Pendino F, Flexor M, Delhommeau F, Buet D, Lanotte M, Segal-Bendirdjian E. Retinoids down-regulate telomerase and telomere length in a pathway distinct from leukemia cell differentiation. Proc Natl Acad Sci U S A 2001;98:6662-7. [PMID: 11371621 DOI: 10.1073/pnas.111464998] [Cited by in Crossref: 64] [Cited by in F6Publishing: 64] [Article Influence: 3.0] [Reference Citation Analysis]
202 Im E, Yoon JB, Lee HW, Chung KC. Human Telomerase Reverse Transcriptase (hTERT) Positively Regulates 26S Proteasome Activity. J Cell Physiol 2017;232:2083-93. [PMID: 27648923 DOI: 10.1002/jcp.25607] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
203 Liu J. Molecular mechanisms regulating telomerase activity. Telomerase, Aging and Disease. Elsevier; 2001. pp. 33-59. [DOI: 10.1016/s1566-3124(01)08003-8] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
204 Won J, Yim J, Kim TK. Sp1 and Sp3 recruit histone deacetylase to repress transcription of human telomerase reverse transcriptase (hTERT) promoter in normal human somatic cells. J Biol Chem 2002;277:38230-8. [PMID: 12151407 DOI: 10.1074/jbc.M206064200] [Cited by in Crossref: 141] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
205 Harrington L. Biochemical aspects of telomerase function. Cancer Lett 2003;194:139-54. [PMID: 12757972 DOI: 10.1016/s0304-3835(02)00701-2] [Cited by in Crossref: 56] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
206 Meeker AK. Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology. Urol Oncol 2006;24:122-30. [PMID: 16520276 DOI: 10.1016/j.urolonc.2005.11.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
207 Fujimoto R, Kamata N, Yokoyama K, Ueda N, Satomura K, Hayashi E, Nagayama M. Expression of telomerase components in oral keratinocytes and squamous cell carcinomas. Oral Oncol 2001;37:132-40. [PMID: 11167139 DOI: 10.1016/s1368-8375(00)00073-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
208 Mitsui A, Kuwabara Y, Iwase H, Mitani M, Shinoda N, Sato A, Toyama T, Sugiura M, Suzuki T, Kato J. Telomerase activity in esophageal squamous cell carcinoma: down-regulation by chemotherapeutic agent. J Surg Oncol. 2002;79:37-45. [PMID: 11754376 DOI: 10.1002/jso.10025] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
209 Osanai M, Tamaki T, Yonekawa M, Kawamura A, Sawada N. Transient increase in telomerase activity of proliferating fibroblasts and endothelial cells in granulation tissue of the human skin. Wound Repair Regen 2002;10:59-66. [PMID: 11983007 DOI: 10.1046/j.1524-475x.2002.10506.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
210 Chong EYY, Pang JCS, Ko CW, Poon WS, Ng HK. Telomere length and telomerase catalytic subunit expression in non-astrocytic gliomas. Pathol Res Pract 2000;196:691-9. [PMID: 11087056 DOI: 10.1016/s0344-0338(00)80121-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
211 Antal M, Boros E, Solymosy F, Kiss T. Analysis of the structure of human telomerase RNA in vivo. Nucleic Acids Res 2002;30:912-20. [PMID: 11842102 DOI: 10.1093/nar/30.4.912] [Cited by in Crossref: 58] [Cited by in F6Publishing: 67] [Article Influence: 2.9] [Reference Citation Analysis]
212 Fiset S, Chabot B. hnRNP A1 may interact simultaneously with telomeric DNA and the human telomerase RNA in vitro. Nucleic Acids Res 2001;29:2268-75. [PMID: 11376145 DOI: 10.1093/nar/29.11.2268] [Cited by in Crossref: 59] [Cited by in F6Publishing: 64] [Article Influence: 2.8] [Reference Citation Analysis]
213 Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, Caddle SD, Ziaugra L, Beijersbergen RL, Davidoff MJ, Liu Q, Bacchetti S, Haber DA, Weinberg RA. hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization. Cell 1997;90:785-95. [DOI: 10.1016/s0092-8674(00)80538-3] [Cited by in Crossref: 1215] [Cited by in F6Publishing: 434] [Article Influence: 48.6] [Reference Citation Analysis]
214 Jong H, Park YI, Kim S, Sohn JH, Kang SH, Song SH, Bang Y, Kim NK. Up-regulation of human telomerase catalytic subunit during gastric carcinogenesis. Cancer 1999;86:559-65. [DOI: 10.1002/(sici)1097-0142(19990815)86:4<559::aid-cncr3>3.0.co;2-4] [Cited by in Crossref: 35] [Article Influence: 1.5] [Reference Citation Analysis]
215 Tang H, Ge L, Shao W, Qiu Y, Cui D. Effect of targeted silencing of hTERT mRNA by lentivirus-mediated siRNA on A549 lung cancer cells in vitro. Mol Biol Rep 2013;40:605-16. [PMID: 23054018 DOI: 10.1007/s11033-012-2099-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
216 Krupp G, Bonatz G, Parwaresch R. Telomerase, immortality and cancer. Elsevier; 2000. pp. 103-40. [DOI: 10.1016/s1387-2656(00)06020-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
217 Fukui T, Nonomura N, Tokizane T, Sato E, Ono Y, Harada Y, Nishimura K, Takahara S, Okuyama A. Clinical Evaluation of Human Telomerase Catalytic Subunit in Bladder Washings from Patients with Bladder Cancer. Molecular Urology 2001;5:19-23. [DOI: 10.1089/109153601750124249] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
218 Akiyama M, Iwase S, Horiguchi-yamada J, Saito S, Furukawa Y, Yamada O, Mizoguchi H, Ohno T, Yamada H. Interferon-α repressed telomerase along with G1-accumulation of Daudi cells. Cancer Letters 1999;142:23-30. [DOI: 10.1016/s0304-3835(99)00109-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
219 Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M, Ariga H, Inoue M. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res. 2000;28:669-677. [PMID: 10637317 DOI: 10.1093/nar/28.3.669] [Cited by in Crossref: 335] [Cited by in F6Publishing: 326] [Article Influence: 15.2] [Reference Citation Analysis]
220 Krams M, Hero B, Berthold F, Parwaresch R, Harms D, Rudolph P. Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastoma. Am J Pathol 2003;162:1019-26. [PMID: 12598334 DOI: 10.1016/S0002-9440(10)63896-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
221 Hammond PW, Cech TR. dGTP-dependent processivity and possible template switching of euplotes telomerase. Nucleic Acids Res 1997;25:3698-704. [PMID: 9278493 DOI: 10.1093/nar/25.18.3698] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 1.2] [Reference Citation Analysis]
222 Moon D, Kim M, Choi YH, Lee HG, Kim ND, Kim G. Gossypol suppresses telomerase activity in human leukemia cells via regulating hTERT. FEBS Letters 2008;582:3367-73. [DOI: 10.1016/j.febslet.2008.08.029] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
223 Wick M, Zubov D, Hagen G. Genomic organization and promoter characterization of the gene encoding the human telomerase reverse transcriptase (hTERT). Gene. 1999;232:97-106. [PMID: 10333526 DOI: 10.1016/s0378-1119(99)00108-0] [Cited by in Crossref: 188] [Cited by in F6Publishing: 84] [Article Influence: 8.2] [Reference Citation Analysis]
224 Zhang X, Dong N, Zhang H, You J, Wang H, Ye L. Effects of hepatitis B virus X protein on human telomerase reverse transcriptase expression and activity in hepatoma cells. J Lab Clin Med. 2005;145:98-104. [PMID: 15746653 DOI: 10.1016/j.lab.2004.11.018] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 2.7] [Reference Citation Analysis]
225 Cowell JK. Telomeres and telomerase in ageing and cancer. Age (Omaha) 1999;22:59-64. [PMID: 23604397 DOI: 10.1007/s11357-999-0007-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
226 Knight JS, Cotter MA 2nd, Robertson ES. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. J Biol Chem 2001;276:22971-8. [PMID: 11313352 DOI: 10.1074/jbc.M101890200] [Cited by in Crossref: 85] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
227 Chakrabarti AK, Ray P, Broomfield CA, Ray R. Purification and characterization of protease activated by sulfur mustard in normal human epidermal keratinocytes. Biochemical Pharmacology 1998;56:467-72. [DOI: 10.1016/s0006-2952(98)00160-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
228 Aravindan N, Veeraraghavan J, Madhusoodhanan R, Herman TS, Natarajan M. Curcumin regulates low-linear energy transfer γ-radiation-induced NFκB-dependent telomerase activity in human neuroblastoma cells. Int J Radiat Oncol Biol Phys 2011;79:1206-15. [PMID: 21236599 DOI: 10.1016/j.ijrobp.2010.10.058] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
229 Kosciolek BA, Rowley PT. Human lymphocyte telomerase is genetically regulated. Genes Chromosom Cancer 1998;21:124-30. [DOI: 10.1002/(sici)1098-2264(199802)21:2<124::aid-gcc8>3.0.co;2-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
230 Takahashi S, Kitamoto M, Takaishi H, Aikata H, Kawakami Y, Nakanishi T, Shimamoto F, Tahara E, Tahara H, Ide T. Expression of telomerase component genes in hepatocellular carcinomas. Eur J Cancer. 2000;36:496-502. [PMID: 10717526 DOI: 10.1016/s0959-8049(99)00284-1] [Cited by in Crossref: 28] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
231 Heald RA, Modi C, Cookson JC, Hutchinson I, Laughton CA, Gowan SM, Kelland LR, Stevens MFG. Antitumor Polycyclic Acridines. 8. Synthesis and Telomerase-Inhibitory Activity of Methylated Pentacyclic Acridinium Salts. J Med Chem 2002;45:590-7. [DOI: 10.1021/jm011015q] [Cited by in Crossref: 97] [Cited by in F6Publishing: 74] [Article Influence: 4.6] [Reference Citation Analysis]
232 Hossain S, Singh S, Lue NF. Functional analysis of the C-terminal extension of telomerase reverse transcriptase. A putative "thumb" domain. J Biol Chem 2002;277:36174-80. [PMID: 12151386 DOI: 10.1074/jbc.M201976200] [Cited by in Crossref: 48] [Cited by in F6Publishing: 26] [Article Influence: 2.4] [Reference Citation Analysis]
233 Bosoy D, Lue NF. Yeast telomerase is capable of limited repeat addition processivity. Nucleic Acids Res 2004;32:93-101. [PMID: 14704347 DOI: 10.1093/nar/gkg943] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.3] [Reference Citation Analysis]
234 Ulaner GA, Hu J, Vu TH, Giudice LC, Hoffman AR. Tissue-specific alternate splicing of human telomerase reverse transcriptase (hTERT) influences telomere lengths during human development. Int J Cancer 2001;91:644-9. [DOI: 10.1002/1097-0215(200002)9999:9999<::aid-ijc1103>3.0.co;2-v] [Cited by in Crossref: 90] [Cited by in F6Publishing: 1] [Article Influence: 4.3] [Reference Citation Analysis]
235 Buseman CM, Wright WE, Shay JW. Is telomerase a viable target in cancer? Mutat Res. 2012;730:90-97. [PMID: 21802433 DOI: 10.1016/j.mrfmmm.2011.07.006] [Cited by in Crossref: 87] [Cited by in F6Publishing: 78] [Article Influence: 7.9] [Reference Citation Analysis]
236 Shippen DE, Mcknight TD. Telomeres, telomerase and plant development. Trends in Plant Science 1998;3:126-30. [DOI: 10.1016/s1360-1385(98)01214-x] [Cited by in Crossref: 22] [Article Influence: 0.9] [Reference Citation Analysis]
237 van Zon A, Mossink MH, Schoester M, Scheffer GL, Scheper RJ, Sonneveld P, Wiemer EA. Multiple human vault RNAs. Expression and association with the vault complex. J Biol Chem 2001;276:37715-21. [PMID: 11479319 DOI: 10.1074/jbc.M106055200] [Cited by in Crossref: 50] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
238 Frascotti G, Galbiati E, Mazzucchelli M, Pozzi M, Salvioni L, Vertemara J, Tortora P. The Vault Nanoparticle: A Gigantic Ribonucleoprotein Assembly Involved in Diverse Physiological and Pathological Phenomena and an Ideal Nanovector for Drug Delivery and Therapy. Cancers (Basel) 2021;13:707. [PMID: 33572350 DOI: 10.3390/cancers13040707] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 van Zon A, Mossink MH, Schoester M, Scheffer GL, Scheper RJ, Sonneveld P, Wiemer EA. Structural domains of vault proteins: a role for the coiled coil domain in vault assembly. Biochem Biophys Res Commun 2002;291:535-41. [PMID: 11855821 DOI: 10.1006/bbrc.2002.6472] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 1.6] [Reference Citation Analysis]
240 Poole JC, Andrews LG, Tollefsbol TO. Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene. 2001;269:1-12. [PMID: 11376932 DOI: 10.1016/s0378-1119(01)00440-1] [Cited by in Crossref: 181] [Cited by in F6Publishing: 66] [Article Influence: 8.6] [Reference Citation Analysis]
241 Pan C, Koeneman K. A novel tumor-specific gene therapy for bladder cancer. Medical Hypotheses 1999;53:130-5. [DOI: 10.1054/mehy.1998.0731] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
242 Reddel RR. The role of senescence and immortalization in carcinogenesis. Carcinogenesis. 2000;21:477-484. [PMID: 10688868 DOI: 10.1093/carcin/21.3.477] [Cited by in Crossref: 134] [Cited by in F6Publishing: 122] [Article Influence: 6.1] [Reference Citation Analysis]
243 Yajima T, Yagihashi A, Kameshima H, Kobayashi D, Hirata K, Watanabe N. Telomerase reverse transcriptase and telomeric-repeat binding factor protein 1 as regulators of telomerase activity in pancreatic cancer cells. Br J Cancer. 2001;85:752-757. [PMID: 11531263 DOI: 10.1054/bjoc.2001.1954] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 0.6] [Reference Citation Analysis]
244 Lipinska N, Romaniuk A, Paszel-Jaworska A, Toton E, Kopczynski P, Rubis B. Telomerase and drug resistance in cancer. Cell Mol Life Sci 2017;74:4121-32. [PMID: 28623509 DOI: 10.1007/s00018-017-2573-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 6.0] [Reference Citation Analysis]
245 Lue NF, Peng Y. Identification and characterization of a telomerase activity from Schizosaccharomyces pombe. Nucleic Acids Res 1997;25:4331-7. [PMID: 9336465 DOI: 10.1093/nar/25.21.4331] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 0.9] [Reference Citation Analysis]
246 Fujimoto K, Takahashi M. Telomerase Activity in Human Leukemic Cell Lines Is Inhibited by Antisense Pentadecadeoxynucleotides Targeted against c-myc mRNA. Biochemical and Biophysical Research Communications 1997;241:775-81. [DOI: 10.1006/bbrc.1997.7806] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 1.6] [Reference Citation Analysis]
247 Yamada O, Ozaki K, Nakatake M, Akiyama M, Kawauchi K, Matsuoka R. Multistep regulation of telomerase during differentiation of HL60 cells. Journal of Leukocyte Biology 2008;83:1240-8. [DOI: 10.1189/jlb.1207848] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
248 Meyerson M. Telomerase enzyme activation and human cell immortalization. Toxicol Lett. 1998;102-103:41-45. [PMID: 10022230 DOI: 10.1016/s0378-4274(98)00278-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
249 Ringel MD. Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma. Rev Endocr Metab Disord 2000;1:173-81. [PMID: 11705003 DOI: 10.1023/a:1010027014324] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
250 Anantharaman V, Koonin EV, Aravind L. Comparative genomics and evolution of proteins involved in RNA metabolism. Nucleic Acids Res 2002;30:1427-64. [PMID: 11917006 DOI: 10.1093/nar/30.7.1427] [Cited by in Crossref: 339] [Cited by in F6Publishing: 336] [Article Influence: 17.0] [Reference Citation Analysis]
251 Moon DO, Kim MO, Heo MS, Lee JD, Choi YH, Kim GY. Gefitinib induces apoptosis and decreases telomerase activity in MDA-MB-231 human breast cancer cells. Arch Pharm Res 2009;32:1351-60. [PMID: 19898796 DOI: 10.1007/s12272-009-2002-7] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.8] [Reference Citation Analysis]
252 Kickhoefer VA, Liu Y, Kong LB, Snow BE, Stewart PL, Harrington L, Rome LH. The Telomerase/vault-associated protein TEP1 is required for vault RNA stability and its association with the vault particle. J Cell Biol 2001;152:157-64. [PMID: 11149928 DOI: 10.1083/jcb.152.1.157] [Cited by in Crossref: 55] [Cited by in F6Publishing: 52] [Article Influence: 2.6] [Reference Citation Analysis]
253 Li W, Tao KX. Advances in research of the epigenetic regulation of hTERT expression. Shijie Huaren Xiaohua Zazhi 2010; 18(10): 1026-1031 [DOI: 10.11569/wcjd.v18.i10.1026] [Reference Citation Analysis]
254 Coviello-McLaughlin GM, Prowse KR. Telomere length regulation during postnatal development and ageing in Mus spretus. Nucleic Acids Res 1997;25:3051-8. [PMID: 9224604 DOI: 10.1093/nar/25.15.3051] [Cited by in Crossref: 100] [Cited by in F6Publishing: 99] [Article Influence: 4.0] [Reference Citation Analysis]
255 Gowan SM, Harrison JR, Patterson L, Valenti M, Read MA, Neidle S, Kelland LR. A G-Quadruplex-Interactive Potent Small-Molecule Inhibitor of Telomerase Exhibiting in Vitro and in Vivo Antitumor Activity. Mol Pharmacol 2002;61:1154-62. [DOI: 10.1124/mol.61.5.1154] [Cited by in Crossref: 197] [Cited by in F6Publishing: 193] [Article Influence: 9.9] [Reference Citation Analysis]
256 Zhang W, Ge K, Zhao Q, Zhuang X, Deng Z, Liu L, Li J, Zhang Y, Dong Y, Zhang Y, Zhang S, Liu B. A novel oHSV-1 targeting telomerase reverse transcriptase-positive cancer cells via tumor-specific promoters regulating the expression of ICP4. Oncotarget 2015;6:20345-55. [PMID: 25972362 DOI: 10.18632/oncotarget.3884] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
257 Sumida T, Hamakawa H. Telomerase and oral cancer. Oral Oncol 2001;37:333-40. [PMID: 11337264 DOI: 10.1016/s1368-8375(00)00132-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
258 Zhou J, Hidaka K, Futcher B. The Est1 subunit of yeast telomerase binds the Tlc1 telomerase RNA. Mol Cell Biol 2000;20:1947-55. [PMID: 10688642 DOI: 10.1128/MCB.20.6.1947-1955.2000] [Cited by in Crossref: 76] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
259 Pendino F, Sahraoui T, Lanotte M, Ségal-bendirdjian E. A novel mechanism of retinoic acid resistance in acute promyelocytic leukemia cells through a defective pathway in telomerase regulation. Leukemia 2002;16:826-32. [DOI: 10.1038/sj.leu.2402470] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
260 Ramakrishnan S, Sharma HW, Farris AD, Kaufman KM, Harley JB, Collins K, Pruijn GJ, van Venrooij WJ, Martin ML, Narayanan R. Characterization of human telomerase complex. Proc Natl Acad Sci USA. 1997;94:10075-10079. [PMID: 9294165 DOI: 10.1073/pnas.94.19.10075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
261 Dong CK, Masutomi K, Hahn WC. Telomerase: regulation, function and transformation. Crit Rev Oncol Hematol 2005;54:85-93. [PMID: 15843091 DOI: 10.1016/j.critrevonc.2004.12.005] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 3.8] [Reference Citation Analysis]
262 Akiyama M, Yamada O, Akita S, Urashima M, Horiguchi-yamada J, Ohno T, Mizoguchi H, Eto Y, Yamada H. Ectopic expression of c-myc fails to overcome downregulation of telomerase activity induced by herbimycin A, but ectopic hTERT expression overcomes it. Leukemia 2000;14:1260-5. [DOI: 10.1038/sj.leu.2401828] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
263 Akiyama M, Horiguchi-yamada J, Saito S, Hoshi Y, Yamada O, Mizoguchi H, Yamada H. Cytostatic concentrations of anticancer agents do not affect telomerase activity of leukaemic cells in vitro. European Journal of Cancer 1999;35:309-15. [DOI: 10.1016/s0959-8049(98)00365-7] [Cited by in Crossref: 30] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
264 Dhaene K, Wauters J, Weyn B, Timmermans J, van Marck E. Expression profile of telomerase subunits in human pleural mesothelioma. J Pathol 2000;190:80-5. [DOI: 10.1002/(sici)1096-9896(200001)190:1<80::aid-path498>3.0.co;2-7] [Cited by in Crossref: 23] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
265 Mohammadi M, Hedayati M, Zarghami N, Ghaemmaghami S. RESISTIN EFFECT ON TELOMERASE GENE EXPRESSION IN GASTRIC CANCER CELL LINE AGS. Acta Endocrinol (Buchar) 2016;12:145-9. [PMID: 31149079 DOI: 10.4183/aeb.2016.145] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
266 Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE, Bodnar AG, Lichtsteiner S, Kim NW, Trager JB. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet. 1997;17:498-502. [PMID: 9398860 DOI: 10.1038/ng1297-498] [Cited by in Crossref: 621] [Cited by in F6Publishing: 628] [Article Influence: 24.8] [Reference Citation Analysis]
267 Kiyozuka Y, Asai A, Yamamoto D, Senzaki H, Yoshioka S, Takahashi H, Hioki K, Tsubura A. Establishment of novel human esophageal cancer cell line in relation to telomere dynamics and telomerase activity. Dig Dis Sci. 2000;45:870-879. [PMID: 10795747 DOI: 10.1023/a:1005504503975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
268 Eller MS, Hadshiew IM, Gilchrest BA. The Role of DNA Damage in Melanogenesis: Potential Role for Telomeres. In: Holick MF, editor. Biologic Effects of Light 2001. Boston: Springer US; 2002. pp. 91-101. [DOI: 10.1007/978-1-4615-0937-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
269 Lingner J, Cech TR, Hughes TR, Lundblad V. Three Ever Shorter Telomere (EST) genes are dispensable for in vitro yeast telomerase activity. Proc Natl Acad Sci USA. 1997;94:11190-11195. [PMID: 9326584 DOI: 10.1073/pnas.94.21.11190] [Cited by in Crossref: 160] [Cited by in F6Publishing: 162] [Article Influence: 6.4] [Reference Citation Analysis]
270 Yokozaki H, Yasui W, Tahara E. Genetic and epigenetic changes in stomach cancer. Int Rev Cytol. 2001;204:49-95. [PMID: 11243597 DOI: 10.1016/s0074-7696(01)04003-7] [Cited by in Crossref: 71] [Cited by in F6Publishing: 22] [Article Influence: 3.4] [Reference Citation Analysis]
271 Won J, Yim J, Kim TK. Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells. FASEB J 2002;16:1943-5. [PMID: 12368233 DOI: 10.1096/fj.02-0311fje] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 2.5] [Reference Citation Analysis]
272 Li H, Cao Y, Berndt MC, Funder JW, Liu JP. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro. Oncogene. 1999;18:6785-6794. [PMID: 10597287 DOI: 10.1038/sj.onc.1203061] [Cited by in Crossref: 58] [Cited by in F6Publishing: 59] [Article Influence: 2.6] [Reference Citation Analysis]
273 Park JG. Effective inhibition of cancer cell growth by a novel tripartite transfection complex containing ribbon antisense molecules to hTR. Cancer Res Treat 2004;36:308-14. [PMID: 20368821 DOI: 10.4143/crt.2004.36.5.308] [Reference Citation Analysis]
274 Bornstein-Quevedo L, García-Hernández ML, Camacho-Arroyo I, Herrera MF, Angeles AA, Treviño OG, Gamboa-Domínguez A. Telomerase activity in well-differentiated papillary thyroid carcinoma correlates with advanced clinical stage of the disease. Endocr Pathol 2003;14:213-19. [PMID: 14586066 DOI: 10.1007/s12022-003-0013-3] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
275 Moon DO, Kang CH, Kim MO, Jeon YJ, Lee JD, Choi YH, Kim GY. Beta-lapachone (LAPA) decreases cell viability and telomerase activity in leukemia cells: suppression of telomerase activity by LAPA. J Med Food 2010;13:481-8. [PMID: 20438329 DOI: 10.1089/jmf.2008.1219] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
276 Albanell J, Engelhardt M, Han W, Moore MAS, Lonardo F, Rusch V, Langenfeld J, Klimstra D, Venkatraman E, Dmitrovsky E. High Telomerase Activity in Primary Lung Cancers: Association With Increased Cell Proliferation Rates and Advanced Pathologic Stage. JNCI Journal of the National Cancer Institute 1997;89:1609-15. [DOI: 10.1093/jnci/89.21.1609] [Cited by in Crossref: 138] [Cited by in F6Publishing: 114] [Article Influence: 5.5] [Reference Citation Analysis]
277 Inada E, Saitoh I, Kubota N, Iwase Y, Kiyokawa Y, Shibasaki S, Noguchi H, Yamasaki Y, Sato M. piggyBac Transposon-Based Immortalization of Human Deciduous Tooth Dental Pulp Cells with Multipotency and Non-Tumorigenic Potential. Int J Mol Sci 2019;20:E4904. [PMID: 31623314 DOI: 10.3390/ijms20194904] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
278 Mossink MH, van Zon A, Scheper RJ, Sonneveld P, Wiemer EA. Vaults: a ribonucleoprotein particle involved in drug resistance? Oncogene 2003;22:7458-67. [PMID: 14576851 DOI: 10.1038/sj.onc.1206947] [Cited by in Crossref: 121] [Cited by in F6Publishing: 112] [Article Influence: 6.4] [Reference Citation Analysis]
279 Yu CC, Lo SC, Wang TC. Telomerase is regulated by protein kinase C-zeta in human nasopharyngeal cancer cells. Biochem J 2001;355:459-64. [PMID: 11284734 DOI: 10.1042/0264-6021:3550459] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
280 Mason DX, Autexier C, Greider CW. Tetrahymena proteins p80 and p95 are not core telomerase components. Proc Natl Acad Sci U S A 2001;98:12368-73. [PMID: 11592988 DOI: 10.1073/pnas.221456398] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.2] [Reference Citation Analysis]
281 Singh SM, Lue NF. Ever shorter telomere 1 (EST1)-dependent reverse transcription by Candida telomerase in vitro: evidence in support of an activating function. Proc Natl Acad Sci U S A 2003;100:5718-23. [PMID: 12716976 DOI: 10.1073/pnas.1036868100] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 1.4] [Reference Citation Analysis]
282 Ram R, Uziel O, Lahav M. The importance of the telomere and telomerase system in hematological malignancies. Leuk Lymphoma 2005;46:1121-35. [PMID: 16085552 DOI: 10.1080/10428190500125853] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
283 Wang Y, Qiao Y, Cheng Y, Su Y, Song L, Xu Y, Li H, Zhang L, Song J, Zhang X, Wang J, Zhu D, Tang T, Shang Q, Gao C, Wang X, Zhu C, Xing Q. TEP1 is a risk gene for sporadic cerebral palsy. J Genet Genomics 2021:S1673-8527(21)00282-4. [PMID: 34543729 DOI: 10.1016/j.jgg.2021.08.010] [Reference Citation Analysis]
284 Tomoda R, Seto M, Tsumuki H, Iida K, Yamazaki T, Sonoda J, Matsumine A, Uchida A. Telomerase activity and human telomerase reverse transcriptase mRNA expression are correlated with clinical aggressiveness in soft tissue tumors. Cancer 2002;95:1127-33. [DOI: 10.1002/cncr.10793] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.5] [Reference Citation Analysis]
285 Yang SM, Fang DC, Yang JL, Chen L, Luo YH, Liang GP. Antisense human telomerase reverse transcriptase could partially reverse malignant phenotypes of gastric carcinoma cell line in vitro. Eur J Cancer Prev 2008;17:209-17. [PMID: 18414191 DOI: 10.1097/CEJ.0b013e3282b71f0d] [Cited by in Crossref: 14] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
286 Beattie TL, Zhou W, Robinson MO, Harrington L. Functional multimerization of the human telomerase reverse transcriptase. Mol Cell Biol 2001;21:6151-60. [PMID: 11509658 DOI: 10.1128/MCB.21.18.6151-6160.2001] [Cited by in Crossref: 94] [Cited by in F6Publishing: 52] [Article Influence: 4.5] [Reference Citation Analysis]
287 Onimaru M, Ohuchida K, Nagai E, Mizumoto K, Egami T, Cui L, Sato N, Uchino J, Takayama K, Hashizume M. Combination with low-dose gemcitabine and hTERT-promoter-dependent conditionally replicative adenovirus enhances cytotoxicity through their crosstalk mechanisms in pancreatic cancer. Cancer Lett. 2010;294:178-186. [PMID: 20163915 DOI: 10.1016/j.canlet.2010.01.034] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
288 Xu D, Gruber A, Björkholm M, Peterson C, Pisa P. Suppression of telomerase reverse transcriptase (hTERT) expression in differentiated HL-60 cells: regulatory mechanisms. Br J Cancer 1999;80:1156-61. [PMID: 10376966 DOI: 10.1038/sj.bjc.6690480] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 2.4] [Reference Citation Analysis]
289 Stewart PL, Makabi M, Lang J, Dickey-Sims C, Robertson AJ, Coffman JA, Suprenant KA. Sea urchin vault structure, composition, and differential localization during development. BMC Dev Biol 2005;5:3. [PMID: 15710043 DOI: 10.1186/1471-213X-5-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
290 Sánchez-alonso P, Guzmán P. Organization of Chromosome Ends in Ustilago maydis. RecQ-like Helicase Motifs at Telomeric Regions. Genetics 1998;148:1043-54. [DOI: 10.1093/genetics/148.3.1043] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.0] [Reference Citation Analysis]
291 Gavory G, Farrow M, Balasubramanian S. Minimum length requirement of the alignment domain of human telomerase RNA to sustain catalytic activity in vitro. Nucleic Acids Res 2002;30:4470-80. [PMID: 12384594 DOI: 10.1093/nar/gkf575] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
292 Kickhoefer VA, Siva AC, Kedersha NL, Inman EM, Ruland C, Streuli M, Rome LH. The 193-kD vault protein, VPARP, is a novel poly(ADP-ribose) polymerase. J Cell Biol 1999;146:917-28. [PMID: 10477748 DOI: 10.1083/jcb.146.5.917] [Cited by in Crossref: 257] [Cited by in F6Publishing: 255] [Article Influence: 11.2] [Reference Citation Analysis]
293 Chakravarti D, LaBella KA, DePinho RA. Telomeres: history, health, and hallmarks of aging. Cell 2021;184:306-22. [PMID: 33450206 DOI: 10.1016/j.cell.2020.12.028] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 11.0] [Reference Citation Analysis]
294 Tanaka H, Shimizu M, Horikawa I, Kugoh H, Yokota J, Barrett JC, Oshimura M. Evidence for a putative telomerase repressor gene in the 3p14.2–p21.1 region. Genes Chromosom Cancer 1998;23:123-33. [DOI: 10.1002/(sici)1098-2264(199810)23:2<123::aid-gcc5>3.0.co;2-4] [Cited by in Crossref: 39] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
295 Prescott J, Blackburn EH. Functionally interacting telomerase RNAs in the yeast telomerase complex. Genes Dev 1997;11:2790-800. [PMID: 9353249 DOI: 10.1101/gad.11.21.2790] [Cited by in Crossref: 106] [Cited by in F6Publishing: 120] [Article Influence: 4.2] [Reference Citation Analysis]
296 Jaeger S, Eriani G, Martin F. Results and prospects of the yeast three-hybrid system. FEBS Letters 2004;556:7-12. [DOI: 10.1016/s0014-5793(03)01434-0] [Cited by in Crossref: 21] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
297 Atoyan RY, Sharov AA, Eller MS, Sargsyan A, Botchkarev VA, Gilchrest BA. Oligonucleotide treatment increases eumelanogenesis, hair pigmentation and melanocortin-1 receptor expression in the hair follicle. Exp Dermatol 2007;16:671-7. [PMID: 17620094 DOI: 10.1111/j.1600-0625.2007.00582.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
298 Counter CM, Meyerson M, Eaton EN, Weinberg RA. The catalytic subunit of yeast telomerase. Proc Natl Acad Sci USA. 1997;94:9202-9207. [PMID: 9256460 DOI: 10.1073/pnas.94.17.9202] [Cited by in Crossref: 169] [Cited by in F6Publishing: 176] [Article Influence: 6.8] [Reference Citation Analysis]
299 Banerjee PP, Jagadeesh S. Non-radioactive assay methods for the assessment of telomerase activity and telomere length. Methods Mol Biol 2009;523:383-94. [PMID: 19381925 DOI: 10.1007/978-1-59745-190-1_25] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
300 Kickhoefer VA, Stephen AG, Harrington L, Robinson MO, Rome LH. Vaults and telomerase share a common subunit, TEP1. J Biol Chem. 1999;274:32712-32717. [PMID: 10551828 DOI: 10.1074/jbc.274.46.32712] [Cited by in Crossref: 98] [Cited by in F6Publishing: 97] [Article Influence: 4.5] [Reference Citation Analysis]
301 Slater MD, Lauer C, Gidley-baird A, Barden JA. Markers for the development of early prostate cancer. J Pathol 2003;199:368-77. [DOI: 10.1002/path.1258] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
302 Wang Q, Bai Z, Li X, Hou L, Zhang B. The evidences of human orphan receptor COUP-TFII inhibiting telomeraseactivity through decreasing hTERT transcription. Cancer Lett. 2004;214:81-90. [PMID: 15331176 DOI: 10.1016/j.canlet.2004.03.032] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
303 Evans S, Lundblad V. Positive and negative regulation of telomerase access to the telomere. Journal of Cell Science 2000;113:3357-64. [DOI: 10.1242/jcs.113.19.3357] [Cited by in Crossref: 66] [Cited by in F6Publishing: 36] [Article Influence: 3.0] [Reference Citation Analysis]
304 Boral AL, Dessain S, Chabner BA. Clinical evaluation of biologically targeted drugs: Obstacles and opportunities. Cancer Chemother Pharmacol 1998;42:S3-S21. [DOI: 10.1007/s002800051075] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
305 Ford LP, Wright WE, Shay JW. A model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation. Oncogene 2002;21:580-3. [PMID: 11850782 DOI: 10.1038/sj.onc.1205086] [Cited by in Crossref: 106] [Cited by in F6Publishing: 105] [Article Influence: 5.3] [Reference Citation Analysis]
306 Hiyama K, Hiyama E, Shay JW. Telomeres and Telomerase in Humans. In: Hiyama K, editor. Telomeres and Telomerase in Cancer. Totowa: Humana Press; 2009. pp. 3-21. [DOI: 10.1007/978-1-60327-879-9_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
307 Masutomi K, Hahn WC. Telomerase and tumorigenesis. Cancer Lett 2003;194:163-72. [PMID: 12757974 DOI: 10.1016/s0304-3835(02)00703-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
308 Bosoy D, Lue NF. Functional analysis of conserved residues in the putative "finger" domain of telomerase reverse transcriptase. J Biol Chem 2001;276:46305-12. [PMID: 11581271 DOI: 10.1074/jbc.M108168200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
309 Horikawa I, Oshimura M, Barrett JC. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence. Mol Carcinog 1998;22:65-72. [DOI: 10.1002/(sici)1098-2744(199806)22:2<65::aid-mc1>3.0.co;2-j] [Cited by in Crossref: 42] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
310 Greider CW. Telomerase activity, cell proliferation, and cancer. Proc Natl Acad Sci USA. 1998;95:90-92. [PMID: 9419332 DOI: 10.1073/pnas.95.1.90] [Cited by in Crossref: 286] [Cited by in F6Publishing: 267] [Article Influence: 11.9] [Reference Citation Analysis]
311 Perrem K, Reddel RR. Telomeres and cell division potential. Prog Mol Subcell Biol 2000;24:173-89. [PMID: 10547863 DOI: 10.1007/978-3-662-06227-2_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
312 Fujimoto K, Kyo S, Takakura M, Kanaya T, Kitagawa Y, Itoh H, Takahashi M, Inoue M. Identification and characterization of negative regulatory elements of the human telomerase catalytic subunit (hTERT) gene promoter: possible role of MZF-2 in transcriptional repression of hTERT. Nucleic Acids Res. 2000;28:2557-2562. [PMID: 10871406 DOI: 10.1093/nar/28.13.2557] [Cited by in Crossref: 80] [Cited by in F6Publishing: 75] [Article Influence: 3.6] [Reference Citation Analysis]
313 O’reilly M, Teichmann SA, Rhodes D. Telomerases. Current Opinion in Structural Biology 1999;9:56-65. [DOI: 10.1016/s0959-440x(99)80008-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
314 Xu D, Gruber A, Peterson C, Pisa P. Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia: Rapid Paper. British Journal of Haematology 1998;102:1367-75. [DOI: 10.1046/j.1365-2141.1998.00969.x] [Cited by in Crossref: 76] [Cited by in F6Publishing: 68] [Article Influence: 5.8] [Reference Citation Analysis]
315 Eitsuka T, Nakagawa K, Ono Y, Tatewaki N, Nishida H, Kurata T, Shoji N, Miyazawa T. Amadori-glycated phosphatidylethanolamine up-regulates telomerase activity in PANC-1 human pancreatic carcinoma cells. FEBS Lett 2012;586:2542-7. [PMID: 22750441 DOI: 10.1016/j.febslet.2012.06.027] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
316 Bhattacharyya S, Keirsey J, Russell B, Kavecansky J, Lillard-Wetherell K, Tahmaseb K, Turchi JJ, Groden J. Telomerase-associated protein 1, HSP90, and topoisomerase IIalpha associate directly with the BLM helicase in immortalized cells using ALT and modulate its helicase activity using telomeric DNA substrates. J Biol Chem 2009;284:14966-77. [PMID: 19329795 DOI: 10.1074/jbc.M900195200] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.8] [Reference Citation Analysis]
317 Liu MY, Nemes A, Zhou QG. The Emerging Roles for Telomerase in the Central Nervous System. Front Mol Neurosci 2018;11:160. [PMID: 29867352 DOI: 10.3389/fnmol.2018.00160] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 7.0] [Reference Citation Analysis]
318 Lee GE, Yu EY, Cho CH, Lee J, Muller MT, Chung IK. DNA-protein kinase catalytic subunit-interacting protein KIP binds telomerase by interacting with human telomerase reverse transcriptase. J Biol Chem 2004;279:34750-5. [PMID: 15190070 DOI: 10.1074/jbc.M401843200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
319 Toshikuni N, Nouso K, Higashi T, Nakatsukasa H, Onishi T, Kaneyoshi T, Kobayashi Y, Kariyama K, Yamamoto K, Tsuji T. Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma. Br J Cancer. 2000;82:833-837. [PMID: 10732755 DOI: 10.1054/bjoc.1999.1008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 1.6] [Reference Citation Analysis]
320 Fujiwara T, Shirakawa Y, Kagawa S. Telomerase-specific oncolytic virotherapy for human gastrointestinal cancer. Expert Rev Anticancer Ther. 2011;11:525-532. [PMID: 21504319 DOI: 10.1586/era.10.200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
321 Chen CJ, Tsai NM, Liu YC, Ho LI, Hsieh HF, Yen CY, Harn HJ. Telomerase activity in human hepatocellular carcinoma: parallel correlation with human telomerase reverse transcriptase (hTERT) mRNA isoform expression but not with cell cycle modulators or c-Myc expression. Eur J Surg Oncol. 2002;28:225-234. [PMID: 11944954 DOI: 10.1053/ejso.2001.1237] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
322 Tanaka H, Horikawa I, Kugoh H, Shimizu M, Barrett JC, Oshimura M. Telomerase-independent senescence of human immortal cells induced by microcell-mediated chromosome transfer. Mol Carcinog 1999;25:249-55. [DOI: 10.1002/(sici)1098-2744(199908)25:4<249::aid-mc3>3.0.co;2-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
323 Allen HK, Klingelhutz AJ. Papillomavirus infection and telomerase activation. Papillomavirus Report 2013;14:155-62. [DOI: 10.1179/095741903225001598] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
324 Liu Y, Snow BE, Hande MP, Baerlocher G, Kickhoefer VA, Yeung D, Wakeham A, Itie A, Siderovski DP, Lansdorp PM, Robinson MO, Harrington L. Telomerase-associated protein TEP1 is not essential for telomerase activity or telomere length maintenance in vivo. Mol Cell Biol 2000;20:8178-84. [PMID: 11027287 DOI: 10.1128/MCB.20.21.8178-8184.2000] [Cited by in Crossref: 51] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
325 Uchiumi F, Watanabe M, Tanuma Si. Characterization of telomere-binding activity of replication factor C large subunit p140. Biochem Biophys Res Commun 1999;258:482-9. [PMID: 10329413 DOI: 10.1006/bbrc.1999.0589] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
326 Maitra A, Yashima K, Rathi A, Timmons CF, Barton Rogers B, Shay JW, Gazdar AF. The RNA component of telomerase as a marker of biologic potential and clinical outcome in childhood neuroblastic tumors. Cancer 1999;85:741-9. [DOI: 10.1002/(sici)1097-0142(19990201)85:3<741::aid-cncr25>3.0.co;2-6] [Cited by in Crossref: 30] [Article Influence: 1.3] [Reference Citation Analysis]
327 Procházková Schrumpfová P, Schořová Š, Fajkus J. Telomere- and Telomerase-Associated Proteins and Their Functions in the Plant Cell. Front Plant Sci 2016;7:851. [PMID: 27446102 DOI: 10.3389/fpls.2016.00851] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
328 Greene EC, Shippen DE. Developmentally programmed assembly of higher order telomerase complexes with distinct biochemical and structural properties. Genes Dev 1998;12:2921-31. [PMID: 9744868 DOI: 10.1101/gad.12.18.2921] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 0.9] [Reference Citation Analysis]
329 Jayasooriya RG, Kang SH, Kang CH, Choi YH, Moon DO, Hyun JW, Chang WY, Kim GY. Apigenin decreases cell viability and telomerase activity in human leukemia cell lines. Food Chem Toxicol 2012;50:2605-11. [PMID: 22617349 DOI: 10.1016/j.fct.2012.05.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
330 Petrenko A, Korolenkova L, Skvortsov D, Fedorova M, Skoblov M, Baranova A, Zvereva M, Rubtsova M, Kisseljov F. Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA. Biochimie 2010;92:1827-31. [DOI: 10.1016/j.biochi.2010.07.015] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
331 Campbell LJ, Fidler C, Eagleton H, Peniket A, Kusec R, Gal S, Littlewood TJ, Wainscoat JS, Boultwood J. hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia. Leukemia. 2006;20:671-679. [PMID: 16498395 DOI: 10.1038/sj.leu.2404141] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 2.4] [Reference Citation Analysis]
332 Hande MP, Samper E, Lansdorp P, Blasco MA. Telomere length dynamics and chromosomal instability in cells derived from telomerase null mice. J Cell Biol 1999;144:589-601. [PMID: 10037783 DOI: 10.1083/jcb.144.4.589] [Cited by in Crossref: 226] [Cited by in F6Publishing: 231] [Article Influence: 9.8] [Reference Citation Analysis]
333 Villa R, Porta CD, Folini M, Daidone MG, Zaffaroni N. Possible Regulation of Telomerase Activity by Transcription and Alternative Splicing of Telomerase Reverse Transcriptase in Human Melanoma. Journal of Investigative Dermatology 2001;116:867-73. [DOI: 10.1046/j.1523-1747.2001.01343.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.4] [Reference Citation Analysis]
334 Yu J, Dubeau L. Telomerase and malignant transformation. Cancer Treat Res 2002;107:213-28. [PMID: 11775451 DOI: 10.1007/978-1-4757-3587-1_9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
335 Blasco MA. The telomerase knockout mouse. Telomerase, Aging and Disease. Elsevier; 2001. pp. 151-65. [DOI: 10.1016/s1566-3124(01)08008-7] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
336 Cech TR. Leben am Ende der Chromosomen: Telomere und Telomerase. Angewandte Chemie 2000;112:34-44. [DOI: 10.1002/(sici)1521-3757(20000103)112:1<34::aid-ange34>3.0.co;2-2] [Cited by in Crossref: 22] [Article Influence: 1.0] [Reference Citation Analysis]
337 Zaffaroni N, Villa R, Folini M. Therapeutic uses of peptide nucleic acids (PNA) in oncology. Int J Pept Res Ther 2005;10:287-96. [DOI: 10.1007/s10989-005-4910-9] [Reference Citation Analysis]
338 Boltze C, Schneider-Stock R, Roessner A, Quednow C, Hoang-Vu C. Function of HSP90 and p23 in the telomerasecomplex of thyroid tumors. Pathol Res Pract. 2003;199:573-579. [PMID: 14621192 DOI: 10.1078/0344-0338-00464] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
339 Ozaki S, Harada K, Sanzen T, Watanabe K, Tsui W, Nakanuma Y. In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion. Hepatology. 1999;30:914-919. [PMID: 10498642 DOI: 10.1002/hep.510300419] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
340 Ji HJ, Rha SY, Jeung HC, Yang SH, An SW, Chung HC. Cyclic induction of senescence with intermittent AZT treatment accelerates both apoptosis and telomere loss. Breast Cancer Res Treat. 2005;93:227-236. [PMID: 16132531 DOI: 10.1007/s10549-005-5156-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 1.2] [Reference Citation Analysis]
341 Kurz DJ, Hong Y, Trivier E, Huang HL, Decary S, Zang GH, Lüscher TF, Erusalimsky JD. Fibroblast growth factor-2, but not vascular endothelial growth factor, upregulates telomerase activity in human endothelial cells. Arterioscler Thromb Vasc Biol 2003;23:748-54. [PMID: 12676798 DOI: 10.1161/01.ATV.0000069624.55424.61] [Cited by in Crossref: 56] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
342 Tanaka H, Tsukihara T. Structural studies of large nucleoprotein particles, vaults. Proc Jpn Acad Ser B Phys Biol Sci 2012;88:416-33. [PMID: 23060231 DOI: 10.2183/pjab.88.416] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
343 Lingner J, Cech TR. Telomerase and chromosome end maintenance. Current Opinion in Genetics & Development 1998;8:226-32. [DOI: 10.1016/s0959-437x(98)80145-7] [Cited by in Crossref: 73] [Cited by in F6Publishing: 37] [Article Influence: 3.0] [Reference Citation Analysis]
344 Bleichert F, Baserga SJ. Ribonucleoprotein multimers and their functions. Crit Rev Biochem Mol Biol 2010;45:331-50. [PMID: 20572804 DOI: 10.3109/10409238.2010.496772] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
345 Liu BC, Larose I, Weinstein LJ, Ahn M, Weinstein MH, Richie JP. Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection. Cancer 2001;92:1943-8. [DOI: 10.1002/1097-0142(20011001)92:7<1943::aid-cncr1713>3.0.co;2-m] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
346 Kilian A, Bowtell DD, Abud HE, Hime GR, Venter DJ, Keese PK, Duncan EL, Reddel RR, Jefferson RA. Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. Hum Mol Genet. 1997;6:2011-2019. [PMID: 9328464 DOI: 10.1093/hmg/6.12.2011] [Cited by in Crossref: 408] [Cited by in F6Publishing: 387] [Article Influence: 16.3] [Reference Citation Analysis]
347 Bednenko J, Melek M, Shippen DE. Reiterative dG addition by Euplotes crassus telomerase during extension of non-telomeric DNA. Nucleic Acids Res 1998;26:3998-4004. [PMID: 9705511 DOI: 10.1093/nar/26.17.3998] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
348 Fletcher TM, Trevino A, Woynarowski JM. Enzymatic activity of endogenous telomerase associated with intact nuclei from human leukemia CEM cells. Biochem Biophys Res Commun 1999;265:51-6. [PMID: 10548489 DOI: 10.1006/bbrc.1999.1626] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.2] [Reference Citation Analysis]
349 Saha B, Chaiwun B, Tsao-Wei DD, Groshen SL, Naritoku WY, Atkinson RD, Taylor CR, Imam SA. Telomerase and markers of cellular proliferation are associated with the progression of cervical intraepithelial neoplasia lesions. Int J Gynecol Pathol 2007;26:214-22. [PMID: 17581401 DOI: 10.1097/01.pgp.0000250146.44592.d2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
350 Li S, Song F, Lei X, Li J, Li F, Tan H. hsa_circ_0004018 suppresses the progression of liver fibrosis through regulating the hsa-miR-660-3p/TEP1 axis. Aging (Albany NY) 2020;12:11517-29. [PMID: 32584784 DOI: 10.18632/aging.103257] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
351 Lundblad V. Telomerase catalysis: a phylogenetically conserved reverse transcriptase. Proc Natl Acad Sci U S A 1998;95:8415-6. [PMID: 9671690 DOI: 10.1073/pnas.95.15.8415] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
352 Helder MN, Wisman GB, van der Zee GJ. Telomerase and telomeres: from basic biology to cancer treatment. Cancer Invest 2002;20:82-101. [PMID: 11855380 DOI: 10.1081/cnv-120000370] [Cited by in Crossref: 31] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
353 Dasgupta P, Sengupta SB. Role of diallyl disulfide-mediated cleavage of c-Myc and Sp-1 in the regulation of telomerase activity in human lymphoma cell line U937. Nutrition 2015;31:1031-7. [PMID: 26059379 DOI: 10.1016/j.nut.2015.02.016] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
354 Miller MC, Collins K. The Tetrahymena p80/p95 complex is required for proper telomere length maintenance and micronuclear genome stability. Mol Cell 2000;6:827-37. [PMID: 11090621 DOI: 10.1016/s1097-2765(05)00078-x] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
355 Ouellette MM, Aisner DL, Savre-Train I, Wright WE, Shay JW. Telomerase activity does not always imply telomere maintenance. Biochem Biophys Res Commun 1999;254:795-803. [PMID: 9920820 DOI: 10.1006/bbrc.1998.0114] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 3.0] [Reference Citation Analysis]
356 Yudoh K, Matsuno H, Nakazawa F, Katayama R, Kimura T. Reconstituting Telomerase Activity Using the Telomerase Catalytic Subunit Prevents the Telomere Shorting and Replicative Senescence in Human Osteoblasts. J Bone Miner Res 2001;16:1453-64. [DOI: 10.1359/jbmr.2001.16.8.1453] [Cited by in Crossref: 70] [Cited by in F6Publishing: 60] [Article Influence: 3.3] [Reference Citation Analysis]
357 Hsiao SJ, Poitras MF, Cook BD, Liu Y, Smith S. Tankyrase 2 poly(ADP-ribose) polymerase domain-deleted mice exhibit growth defects but have normal telomere length and capping. Mol Cell Biol. 2006;26:2044-2054. [PMID: 16507985 DOI: 10.1128/MCB.26.6.2044-2054.2006] [Cited by in Crossref: 52] [Cited by in F6Publishing: 31] [Article Influence: 3.3] [Reference Citation Analysis]
358 Schnapp G, Rodi HP, Rettig WJ, Schnapp A, Damm K. One-step affinity purification protocol for human telomerase. Nucleic Acids Res 1998;26:3311-3. [PMID: 9628936 DOI: 10.1093/nar/26.13.3311] [Cited by in Crossref: 69] [Cited by in F6Publishing: 71] [Article Influence: 2.9] [Reference Citation Analysis]
359 Folini M, Pennati M, Zaffaroni N. RNA interference-mediated validation of genes involved in telomere maintenance and evasion of apoptosis as cancer therapeutic targets. Methods Mol Biol 2009;487:303-30. [PMID: 19301654 DOI: 10.1007/978-1-60327-547-7_15] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.1] [Reference Citation Analysis]
360 Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, Greider CW. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell. 1997;91:25-34. [PMID: 9335332 DOI: 10.1016/s0092-8674(01)80006-4] [Cited by in Crossref: 1454] [Cited by in F6Publishing: 622] [Article Influence: 58.2] [Reference Citation Analysis]
361 Kim MO, Moon DO, Choi YH, Shin DY, Kang HS, Choi BT, Lee JD, Li W, Kim GY. Platycodin D induces apoptosis and decreases telomerase activity in human leukemia cells. Cancer Lett 2008;261:98-107. [PMID: 18093727 DOI: 10.1016/j.canlet.2007.11.010] [Cited by in Crossref: 50] [Cited by in F6Publishing: 49] [Article Influence: 3.6] [Reference Citation Analysis]
362 Shay JW. Molecular pathogenesis of aging and cancer: are telomeres and telomerase the connection? J Clin Pathol 1997;50:799-800. [PMID: 9462257 DOI: 10.1136/jcp.50.10.799] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
363 Kanzawa T, Germano IM, Kondo Y, Ito H, Kyo S, Kondo S. Inhibition of telomerase activity in malignant glioma cells correlates with their sensitivity to temozolomide. Br J Cancer 2003;89:922-9. [PMID: 12942127 DOI: 10.1038/sj.bjc.6601193] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 2.7] [Reference Citation Analysis]
364 Kyo S, Kanaya T, Takakura M, Tanaka M, Inoue M. Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer 1999;80:60-3. [PMID: 9935231 DOI: 10.1002/(sici)1097-0215(19990105)80:1<60::aid-ijc12>3.0.co;2-e] [Cited by in Crossref: 76] [Cited by in F6Publishing: 26] [Article Influence: 3.3] [Reference Citation Analysis]
365 Benjamin S, Baran N, Manor H. Interference footprinting analysis of telomerase elongation complexes. Mol Cell Biol 2000;20:4224-37. [PMID: 10825187 DOI: 10.1128/MCB.20.12.4224-4237.2000] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
366 Zhang RG, Guo LX, Wang XW, Xie H. Telomerase inhibition and telomere loss in BEL-7404 human hepatoma cells treated with doxorubicin. World J Gastroenterol 2002; 8(5): 827-831 [PMID: 12378624 DOI: 10.3748/wjg.v8.i5.827] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
367 Alvarez-Salas LM, Arpawong TE, DiPaolo JA. Growth inhibition of cervical tumor cells by antisense oligodeoxynucleotides directed to the human papillomavirus type 16 E6 gene. Antisense Nucleic Acid Drug Dev 1999;9:441-50. [PMID: 10555151 DOI: 10.1089/oli.1.1999.9.441] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
368 Yamada K, Yajima T, Yagihashi A, Kobayashi D, Koyanagi Y, Asanuma K, Yamada M, Moriai R, Kameshima H, Watanabe N. Role of human telomerase reverse transcriptase and telomeric-repeat binding factor proteins 1 and 2 in human hematopoietic cells. Jpn J Cancer Res 2000;91:1278-84. [PMID: 11123427 DOI: 10.1111/j.1349-7006.2000.tb00915.x] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
369 Slater M, Scolyer RA, Gidley-Baird A, Thompson JF, Barden JA. Increased expression of apoptotic markers in melanoma. Melanoma Res. 2003;13:137-145. [PMID: 12690296 DOI: 10.1097/00008390-200304000-00005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 1.9] [Reference Citation Analysis]
370 Dhaene K, Vancoillie G, Lambert J, Naeyaert JM, Van Marck E. Absence of telomerase activity and telemorase catalytic subunit mRNA in melanocyte cultures. Br J Cancer 2000;82:1051-7. [PMID: 10737388 DOI: 10.1054/bjoc.1999.1041] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
371 Fujiwara T. Multidisciplinary oncolytic virotherapy for gastrointestinal cancer. Ann Gastroenterol Surg 2019;3:396-404. [PMID: 31346579 DOI: 10.1002/ags3.12270] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
372 Weng NP, Palmer LD, Levine BL, Lane HC, June CH, Hodes RJ. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunol Rev 1997;160:43-54. [PMID: 9476664 DOI: 10.1111/j.1600-065x.1997.tb01026.x] [Cited by in Crossref: 134] [Cited by in F6Publishing: 45] [Article Influence: 5.6] [Reference Citation Analysis]
373 Zeng X, Yuan X, Cai Q, Tang C, Gao J. Circular RNA as An Epigenetic Regulator in Chronic Liver Diseases. Cells 2021;10:1945. [PMID: 34440714 DOI: 10.3390/cells10081945] [Reference Citation Analysis]
374 Nowak JA. Telomerase, Cervical Cancer, and Human Papillomavirus. Clinics in Laboratory Medicine 2000;20:369-82. [DOI: 10.1016/s0272-2712(18)30066-0] [Cited by in Crossref: 15] [Article Influence: 0.7] [Reference Citation Analysis]
375 Yajima T, Yagihashi A, Kameshima H, Furuya D, Kobayashi D, Hirata K, Watanabe N. Establishment of quantitative reverse transcription--polymerase chain reaction assays for human telomerase-associated genes. Clin Chim Acta. 2000;290:117-127. [PMID: 10660803 DOI: 10.1016/s0009-8981(99)00188-6] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
376 Mitchell JR, Cheng J, Collins K. A box H/ACA small nucleolar RNA-like domain at the human telomerase RNA 3' end. Mol Cell Biol. 1999;19:567-576. [PMID: 9858580 DOI: 10.1128/mcb.19.1.567] [Cited by in Crossref: 325] [Cited by in F6Publishing: 209] [Article Influence: 14.1] [Reference Citation Analysis]
377 Sumida T, Hamakawa H, Sogawa K, Sugita A, Tanioka H, Ueda N. Telomerase components as a diagnostic tool in human oral lesions. Int J Cancer 1999;80:1-4. [DOI: 10.1002/(sici)1097-0215(19990105)80:1<1::aid-ijc1>3.0.co;2-u] [Cited by in Crossref: 28] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
378 Kiaris H, Schally AV. Decrease in telomerase activity in U-87MG human glioblastomas after treatment with an antagonist of growth hormone-releasing hormone. Proc Natl Acad Sci U S A 1999;96:226-31. [PMID: 9874800 DOI: 10.1073/pnas.96.1.226] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 2.3] [Reference Citation Analysis]
379 Nagasaka A, Oda N, Nakai A, Hotta K, Nagata M, Kato T, Suzuki A, Itoh M, Miura H, Hakuta M, Yoshida S, Hibi Y, Iwase K. Thyroglobulin may affect telomerase activity in thyroid follicular cells. J Enzyme Inhib Med Chem 2009;24:524-30. [PMID: 18830915 DOI: 10.1080/14756360802218920] [Reference Citation Analysis]
380 Zaffaroni N, Villa R, Folini M. Therapeutic uses of peptide nucleic acids (PNA) in oncology. Int J Pept Res Ther 2003;10:287-96. [DOI: 10.1007/s10989-004-4910-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
381 Reichman TW, Albanell J, Wang X, Moore MA, Studzinski GP. Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase-associated protein. J Cell Biochem 1997;67:13-23. [DOI: 10.1002/(sici)1097-4644(19971001)67:1<13::aid-jcb2>3.0.co;2-z] [Cited by in Crossref: 28] [Article Influence: 1.1] [Reference Citation Analysis]
382 Greene EC, Bednenko J, Shippen DE. Flexible positioning of the telomerase-associated nuclease leads to preferential elimination of nontelomeric DNA. Mol Cell Biol 1998;18:1544-52. [PMID: 9488471 DOI: 10.1128/MCB.18.3.1544] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
383 Zhang B, Kraemer B, SenGupta D, Fields S, Wickens M. Yeast three-hybrid system to detect and analyze interactions between RNA and protein. Methods Enzymol 1999;306:93-113. [PMID: 10432449 DOI: 10.1016/s0076-6879(99)06007-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 0.9] [Reference Citation Analysis]
384 Wang T, Xue Y, Wang M, Sun Q. Silencing of the hTERT gene through RNA interference induces apoptosis via bax/bcl-2 in human glioma cells. Oncol Rep 2012;28:1153-8. [PMID: 22895663 DOI: 10.3892/or.2012.1952] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
385 Yamamoto Y, Hirakawa E. Telomerase activity and hTERT mRNA expression in body fluids. Diagn Cytopathol 2005;32:167-70. [DOI: 10.1002/dc.20204] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
386 Kheirollahi M, Mehrazin M, Kamalian N, Mehdipour P. Alterations of telomere length in human brain tumors. Med Oncol 2011;28:864-70. [PMID: 20373057 DOI: 10.1007/s12032-010-9506-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
387 Jacob S, Nayak S, Kakar R, Chaudhari UK, Joshi D, Vundinti BR, Fernandes G, Barai RS, Kholkute SD, Sachdeva G. A triad of telomerase, androgen receptor and early growth response 1 in prostate cancer cells. Cancer Biol Ther 2016;17:439-48. [PMID: 27003515 DOI: 10.1080/15384047.2016.1156255] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
388 Renaud S, Bosman FT, Benhattar J. Implication of the exon region in the regulation of the human telomerase reverse transcriptase gene promoter. Biochem Biophys Res Commun 2003;300:47-54. [PMID: 12480519 DOI: 10.1016/s0006-291x(02)02775-4] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
389 Gandhi L, Collins K. Interaction of recombinant Tetrahymena telomerase proteins p80 and p95 with telomerase RNA and telomeric DNA substrates. Genes Dev 1998;12:721-33. [PMID: 9499406 DOI: 10.1101/gad.12.5.721] [Cited by in Crossref: 43] [Cited by in F6Publishing: 50] [Article Influence: 1.8] [Reference Citation Analysis]
390 Kosciolek BA, Rowley PT. Telomere-related components are coordinately synthesized during human T-lymphocyte activation. Leukemia Research 1999;23:1097-103. [DOI: 10.1016/s0145-2126(99)00134-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
391 Deelen J, Uh HW, Monajemi R, van Heemst D, Thijssen PE, Böhringer S, van den Akker EB, de Craen AJ, Rivadeneira F, Uitterlinden AG, Westendorp RG, Goeman JJ, Slagboom PE, Houwing-Duistermaat JJ, Beekman M. Gene set analysis of GWAS data for human longevity highlights the relevance of the insulin/IGF-1 signaling and telomere maintenance pathways. Age (Dordr) 2013;35:235-49. [PMID: 22113349 DOI: 10.1007/s11357-011-9340-3] [Cited by in Crossref: 70] [Cited by in F6Publishing: 64] [Article Influence: 6.4] [Reference Citation Analysis]
392 Yoo J, Park SY, Kang SJ, Kim BK, Shim SI, Kang CS. Expression of telomerase activity, human telomerase RNA, and telomerase reverse transcriptase in gastric adenocarcinomas. Mod Pathol. 2003;16:700-707. [PMID: 12861067 DOI: 10.1097/01.MP.0000077517.44687.B6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
393 Kubuki Y, Suzuki M, Sasaki H, Toyama T, Yamashita K, Maeda K, Ido A, Matsuoka H, Okayama A, Nakanishi T, Tsubouchi H. Telomerase activity and telomere length as prognostic factors of adult T-cell leukemia. Leuk Lymphoma 2005;46:393-9. [PMID: 15621829 DOI: 10.1080/10428190400018349] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.2] [Reference Citation Analysis]
394 Bravaccini S, Casadio V, Amadori D, Calistri D, Silvestrini R. The current role of telomerase in the diagnosis of bladder cancer. Indian J Urol 2009;25:40-6. [PMID: 19468427 DOI: 10.4103/0970-1591.45535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
395 Frederickson RM. Macromolecular matchmaking: advances in two-hybrid and related technologies. Curr Opin Biotechnol 1998;9:90-6. [PMID: 9503594 DOI: 10.1016/s0958-1669(98)80090-6] [Cited by in Crossref: 34] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
396 Armstrong L, Lako M, van Herpe I, Evans J, Saretzki G, Hole N. A role for nucleoprotein Zap3 in the reduction of telomerase activity during embryonic stem cell differentiation. Mechanisms of Development 2004;121:1509-22. [DOI: 10.1016/j.mod.2004.07.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
397 Tajima K, Ito Y, Demachi A, Nishida K, Akatsuka Y, Tsujimura K, Hida T, Morishima Y, Kuwano H, Mitsudomi T, Takahashi T, Kuzushima K. Interferon-? differentially regulates susceptibility of lung cancer cells to telomerase-specific cytotoxic T lymphocytes. Int J Cancer 2004;110:403-12. [DOI: 10.1002/ijc.20139] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
398 Tollefsbol T, Andrews L. Mechanisms for telomerase gene control in aging cells and tumorigenesis. Medical Hypotheses 2001;56:630-7. [DOI: 10.1054/mehy.2000.1241] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
399 Komata T, Kanzawa T, Kondo Y, Kondo S. Telomerase as a therapeutic target for malignant gliomas. Oncogene. 2002;21:656-663. [PMID: 11850793 DOI: 10.1038/sj.onc.1205072] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 2.4] [Reference Citation Analysis]
400 Lehner R, Enomoto T, McGregor JA, Shroyer AL, Haugen BR, Pugazhenthi U, Shroyer KR. Quantitative analysis of telomerase hTERT mRNA and telomerase activity in endometrioid adenocarcinoma and in normal endometrium. Gynecol Oncol. 2002;84:120-125. [PMID: 11748987 DOI: 10.1006/gyno.2001.6474] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 1.7] [Reference Citation Analysis]
401 Poderycki MJ, Rome LH, Harrington L, Kickhoefer VA. The p80 homology region of TEP1 is sufficient for its association with the telomerase and vault RNAs, and the vault particle. Nucleic Acids Res 2005;33:893-902. [PMID: 15701761 DOI: 10.1093/nar/gki234] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.2] [Reference Citation Analysis]
402 Rama S, Suresh Y, Rao AJ. Regulation of telomerase during human placental differentiation: a role for TGFbeta1. Mol Cell Endocrinol. 2001;182:233-248. [PMID: 11514058 DOI: 10.1016/S0303-7207(01)00550-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
403 Martin F. Fifteen years of the yeast three-hybrid system: RNA-protein interactions under investigation. Methods 2012;58:367-75. [PMID: 22841566 DOI: 10.1016/j.ymeth.2012.07.016] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
404 Je KH, Kim KN, Nam KW, Cho MH, Mar W. TERT mRNA expression is up-regulated in MCF-7 cells and a mouse mammary organ culture (MMOC) system by endosulfan treatment. Arch Pharm Res 2005;28:351-7. [PMID: 15832825 DOI: 10.1007/BF02977804] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
405 Suzuki K, Kashimura H, Ohkawa J, Itabashi M, Watanabe T, Sawahata T, Nakahara A, Muto H, Tanaka N. Expression of human telomerase catalytic subunit gene in cancerous and precancerous gastric conditions. Journal of Gastroenterology and Hepatology 2001;15:744-51. [DOI: 10.1046/j.1440-1746.2000.02236.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
406 Niiyama H, Mizumoto K, Sato N, Nagai E, Mibu R, Fukui T, Kinoshita M, Tanaka M. Quantitative analysis of hTERT mRNA expression in colorectal cancer. Am J Gastroenterology 2001;96:1895-900. [DOI: 10.1111/j.1572-0241.2001.03890.x] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
407 Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Nakanishi E, Ide T, Ishikawa F. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998;18:65-8. [DOI: 10.1038/ng0198-65] [Cited by in Crossref: 418] [Cited by in F6Publishing: 395] [Article Influence: 17.4] [Reference Citation Analysis]
408 O'Flatharta C, Leader M, Kay E, Flint SR, Toner M, Robertson W, Mabruk MJ. Telomerase activity detected in oral lichen planus by RNA in situ hybridisation: not a marker for malignant transformation. J Clin Pathol 2002;55:602-7. [PMID: 12147655 DOI: 10.1136/jcp.55.8.602] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 0.8] [Reference Citation Analysis]
409 Mikyas Y, Makabi M, Raval-Fernandes S, Harrington L, Kickhoefer VA, Rome LH, Stewart PL. Cryoelectron microscopy imaging of recombinant and tissue derived vaults: localization of the MVP N termini and VPARP. J Mol Biol 2004;344:91-105. [PMID: 15504404 DOI: 10.1016/j.jmb.2004.09.021] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 3.4] [Reference Citation Analysis]
410 Puri N, Eller MS, Byers HR, Dykstra S, Kubera J, Gilchrest BA. Telomere-based DNA damage responses: a new approach to melanoma. FASEB J 2004;18:1373-81. [PMID: 15333580 DOI: 10.1096/fj.04-1774com] [Cited by in Crossref: 64] [Cited by in F6Publishing: 61] [Article Influence: 3.8] [Reference Citation Analysis]
411 Jin L, Dai F, An L. Application of DNA sequencing in detection of telomerase activity. Biochemical Engineering Journal 2002;11:79-85. [DOI: 10.1016/s1369-703x(02)00030-x] [Reference Citation Analysis]
412 Zhou JH, Zhang HM, Chen Q, Han DD, Pei F, Zhang LS, Yang DT. Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma. World J Gastroenterol 2003; 9(8): 1808-1814 [PMID: 12918126 DOI: 10.3748/wjg.v9.i8.1808] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
413 Hara H, Yamashita K, Shinada J, Yoshimura H, Kameya T. Clinicopathologic significance of telomerase activity and hTERT mRNA expression in non-small cell lung cancer. Lung Cancer 2001;34:219-26. [DOI: 10.1016/s0169-5002(01)00244-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
414 Gilley D, Blackburn EH. The telomerase RNA pseudoknot is critical for the stable assembly of a catalytically active ribonucleoprotein. Proc Natl Acad Sci USA. 1999;96:6621-6625. [PMID: 10359761 DOI: 10.1073/pnas.96.12.6621] [Cited by in Crossref: 67] [Cited by in F6Publishing: 71] [Article Influence: 2.9] [Reference Citation Analysis]
415 Shay JW, Wright WE. Telomeres and telomerase: three decades of progress. Nat Rev Genet 2019;20:299-309. [PMID: 30760854 DOI: 10.1038/s41576-019-0099-1] [Cited by in Crossref: 195] [Cited by in F6Publishing: 194] [Article Influence: 65.0] [Reference Citation Analysis]
416 Pandita TK. Telomerase and the cell cycle. Telomerase, Aging and Disease. Elsevier; 2001. pp. 61-88. [DOI: 10.1016/s1566-3124(01)08004-x] [Cited by in Crossref: 2] [Article Influence: 0.1] [Reference Citation Analysis]
417 Ulaner GA, Hu J, Vu TH, Oruganti H, Giudice LC, Andrew R. Hoffman. Regulation of telomerase by alternate splicing of human telomerase reverse transcriptase (hTERT) in normal and neoplastic ovary, endometrium and myometrium. Int J Cancer 2000;85:330-5. [DOI: 10.1002/(sici)1097-0215(20000201)85:3<330::aid-ijc6>3.0.co;2-u] [Cited by in Crossref: 119] [Article Influence: 5.4] [Reference Citation Analysis]
418 Hsu C, Wang P, Ko J, Chen G, Chang H, Yang S, Chen S, Lin L. Concurrent high expression of human telomerase reverse transcriptase and human nonmetastatic clone 23 in high-grade squamous intraepithelial neoplasia and squamous cell carcinoma of uterine cervix. Int J Gynecol Cancer 2007;17:851-7. [DOI: 10.1111/j.1525-1438.2007.00894.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
419 Evans SK, Bertuch AA, Lundblad V. Telomeres and telomerase: at the end, it all comes together. Trends Cell Biol 1999;9:329-31. [PMID: 10490336 DOI: 10.1016/s0962-8924(99)01596-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
420 Kraveka JM, Schady D, Obeid LM, Ogretmen B. Immunoprecipitation of human telomerase reverse transcriptase with telomerase activity. Anal Biochem 2001;291:166-9. [PMID: 11262172 DOI: 10.1006/abio.2001.5033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
421 Withers JB, Ashvetiya T, Beemon KL. Exclusion of exon 2 is a common mRNA splice variant of primate telomerase reverse transcriptases. PLoS One 2012;7:e48016. [PMID: 23110161 DOI: 10.1371/journal.pone.0048016] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
422 Suzuki T, Suzuki Y, Fujioka T. Expression of the catalytic subunit associated with telomerase gene in human urinary bladder cancer. J Urol. 1999;162:2217-2220. [PMID: 10569622 DOI: 10.1016/s0022-5347(05)68162-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
423 Tu W, Zhang D, Cheung P, Tsao S, Lau Y. Effect of insulin-like growth factor 1 on PHA-stimulated cord blood mononuclear cell telomerase activity: IGF-1 regulates Telomerase in Cord Blood MNC. British Journal of Haematology 1999;104:785-94. [DOI: 10.1046/j.1365-2141.1999.01272.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
424 Sheng WY, Chen YR, Wang TC. A major role of PKC theta and NFkappaB in the regulation of hTERT in human T lymphocytes. FEBS Lett 2006;580:6819-24. [PMID: 17141225 DOI: 10.1016/j.febslet.2006.11.044] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
425 Lue NF, Lin YC, Mian IS. A conserved telomerase motif within the catalytic domain of telomerase reverse transcriptase is specifically required for repeat addition processivity. Mol Cell Biol. 2003;23:8440-8449. [PMID: 14612390 DOI: 10.1128/mcb.23.23.8440-8449.2003] [Cited by in Crossref: 55] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
426 Liu BC, Loughlin KR. TELOMERASE IN HUMAN BLADDER CANCER. Urologic Clinics of North America 2000;27:115-23. [DOI: 10.1016/s0094-0143(05)70239-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
427 Liu Y, Snow BE, Kickhoefer VA, Erdmann N, Zhou W, Wakeham A, Gomez M, Rome LH, Harrington L. Vault poly(ADP-ribose) polymerase is associated with mammalian telomerase and is dispensable for telomerase function and vault structure in vivo. Mol Cell Biol. 2004;24:5314-5323. [PMID: 15169895 DOI: 10.1128/mcb.24.12.5314-5323.2004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
428 Zhang RG, Zhang RP, Wang XW, Xie H. Effects of cisplatin on telomerase activity and telomere length in BEL-7404 human hepatoma cells. Cell Res 2002;12:55-62. [PMID: 11942411 DOI: 10.1038/sj.cr.7290110] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 1.3] [Reference Citation Analysis]
429 Autexier C, Triki I. Tetrahymena telomerase ribonucleoprotein RNA-protein interactions. Nucleic Acids Res 1999;27:2227-34. [PMID: 10219097 DOI: 10.1093/nar/27.10.2227] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 0.3] [Reference Citation Analysis]
430 Tahara H, Yasui W, Tahara E, Fujimoto J, Ito K, Tamai K, Nakayama J, Ishikawa F, Tahara E, Ide T. Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections. Oncogene 1999;18:1561-7. [PMID: 10102626 DOI: 10.1038/sj.onc.1202458] [Cited by in Crossref: 103] [Cited by in F6Publishing: 103] [Article Influence: 4.5] [Reference Citation Analysis]
431 Li C, Wu MY, Liang YR, Wu XY. Correlation between expression of human telomerase subunits and telomerase activity in esophageal squamous cell carcinoma. World J Gastroenterol 2003; 9(11): 2395-2399 [PMID: 14606063 DOI: 10.3748/wjg.v9.i11.2395] [Cited by in CrossRef: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.0] [Reference Citation Analysis]
432 Polychronopoulou S, Koutroumba P. Telomere Length and Telomerase Activity: Variations With Advancing Age and Potential Role in Childhood Malignancies: . Journal of Pediatric Hematology/Oncology 2004;26:342-50. [DOI: 10.1097/00043426-200406000-00003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
433 Niida H, Matsumoto T, Satoh H, Shiwa M, Tokutake Y, Furuichi Y, Shinkai Y. Severe growth defect in mouse cells lacking the telomerase RNA component. Nat Genet 1998;19:203-6. [PMID: 9620783 DOI: 10.1038/580] [Cited by in Crossref: 107] [Cited by in F6Publishing: 107] [Article Influence: 4.5] [Reference Citation Analysis]
434 Hsu CP, Miaw J, Hsia JY, Shai SE, Chen CY. Concordant expression of the telomerase-associated genes in non-small cell lung cancer. Eur J Surg Oncol 2003;29:594-9. [PMID: 12943625 DOI: 10.1016/s0748-7983(03)00108-2] [Cited by in Crossref: 21] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
435 Elenitoba-Johnson KS. Complex regulation of telomerase activity: implications for cancer therapy. Am J Pathol 2001;159:405-10. [PMID: 11485897 DOI: 10.1016/S0002-9440(10)61710-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
436 Koga S, Hirohata S, Kondo Y, Komata T, Takakura M, Inoue M, Kyo S, Kondo S. A novel telomerase-specific gene therapy: gene transfer of caspase-8 utilizing the human telomerase catalytic subunit gene promoter. Hum Gene Ther. 2000;11:1397-1406. [PMID: 10910137 DOI: 10.1089/10430340050057477] [Cited by in Crossref: 80] [Cited by in F6Publishing: 74] [Article Influence: 3.6] [Reference Citation Analysis]
437 Yokoyama Y, Takahashi Y, Shinohara A, Wan X, Takahashi S, Niwa K, Tamaya T. The 5'-end of hTERT mRNA is a good target for hammerhead ribozyme to suppress telomerase activity. Biochem Biophys Res Commun. 2000;273:316-321. [PMID: 10873604 DOI: 10.1006/bbrc.2000.2939] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.5] [Reference Citation Analysis]
438 Natarajan M, Mohan S, Konopinski R, Otto RA, Herman TS. Induced telomerase activity in primary aortic endothelial cells by low-LET gamma-radiation is mediated through NF-kappaB activation. Br J Radiol 2008;81:711-20. [PMID: 18541630 DOI: 10.1259/bjr/57867919] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
439 Smith S. The world according to PARP. Trends Biochem Sci 2001;26:174-9. [PMID: 11246023 DOI: 10.1016/s0968-0004(00)01780-1] [Cited by in Crossref: 210] [Cited by in F6Publishing: 65] [Article Influence: 10.0] [Reference Citation Analysis]
440 Olaussen KA, Dubrana K, Domont J, Spano J, Sabatier L, Soria J. Telomeres and telomerase as targets for anticancer drug development. Critical Reviews in Oncology/Hematology 2006;57:191-214. [DOI: 10.1016/j.critrevonc.2005.08.007] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 4.3] [Reference Citation Analysis]
441 Seimiya H, Tanji M, Oh-hara T, Tomida A, Naasani I, Tsuruo T. Hypoxia Up-Regulates Telomerase Activity via Mitogen-Activated Protein Kinase Signaling in Human Solid Tumor Cells. Biochemical and Biophysical Research Communications 1999;260:365-70. [DOI: 10.1006/bbrc.1999.0910] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 2.9] [Reference Citation Analysis]
442 Bachand F, Autexier C. Functional reconstitution of human telomerase expressed in Saccharomyces cerevisiae. J Biol Chem 1999;274:38027-31. [PMID: 10608871 DOI: 10.1074/jbc.274.53.38027] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 2.0] [Reference Citation Analysis]
443 Poderycki MJ, Kickhoefer VA, Kaddis CS, Raval-Fernandes S, Johansson E, Zink JI, Loo JA, Rome LH. The vault exterior shell is a dynamic structure that allows incorporation of vault-associated proteins into its interior. Biochemistry 2006;45:12184-93. [PMID: 17002318 DOI: 10.1021/bi0610552] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 3.1] [Reference Citation Analysis]
444 Fitzgerald MS, Riha K, Gao F, Ren S, McKnight TD, Shippen DE. Disruption of the telomerase catalytic subunit gene from Arabidopsis inactivates telomerase and leads to a slow loss of telomeric DNA. Proc Natl Acad Sci U S A 1999;96:14813-8. [PMID: 10611295 DOI: 10.1073/pnas.96.26.14813] [Cited by in Crossref: 139] [Cited by in F6Publishing: 145] [Article Influence: 6.3] [Reference Citation Analysis]
445 Wang H, Wang X, Zhou G, Wang W, Sun Y, Yang S, Fang D. PinX1 Inhibits Telomerase Activity in Gastric Cancer Cells Through Mad1/c-Myc Pathway. J Gastrointest Surg 2010;14:1227-34. [DOI: 10.1007/s11605-010-1253-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.2] [Reference Citation Analysis]
446 Jiang YA, Luo HS, Zhang YY, Fan LF, Jiang CQ, Chen WJ. Telomerase activity and cell apoptosis in colon cancer cell by human telomerase reverse transcriptase gene antisense oligodeoxynucleotide. World J Gastroenterol 2003; 9(9): 1981-1984 [PMID: 12970889 DOI: 10.3748/wjg.v9.i9.1981] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]